id string | question string | answer string | reasoning_steps list | question_type string | hop_count int32 | topology string | motif string | pattern string | document_relationship string | sector string | sub_industry string | difficulty string | idf_score float64 | quality_score int32 | nodes list | hops list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
qualitative_2hop_cross_company-00700 | How does Johnson & Johnson's licensing arrangement for DARZALEX, as stated in its 2024 10-K filing, relate to Amgen's competitive landscape in the U.S. and Europe, given Amgen lists DARZALEX as a competitor-marketed product? | Johnson & Johnson's 2024 10-K filing states that DARZALEX is licensed from Genmab A/S, indicating JNJ's exclusive rights to market the product. Amgen's 2024 10-K lists DARZALEX as a competitor-marketed product in the U.S. and Europe, showing that DARZALEX competes directly with Amgen's products in these markets. This i... | [
"Step 1: Extract from source A - Amgen lists DARZALEX as a competitor-marketed product in the U.S. and Europe.",
"Step 2: Extract from source B - Johnson & Johnson licenses DARZALEX from Genmab A/S, giving JNJ exclusive rights to market the product.",
"Step 3: Synthesize - JNJ's licensing of DARZALEX creates a ... | qualitative | 2 | cross_company | chain | ORG -[Competes_With]-> PRODUCT <-[Partners_With]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "AMGN",
"name": "AMGN",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "DARZALEX",
"name": "DARZALEX",
"type": "PRODUCT",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
"id":... | [
{
"hop": 1,
"relationship": "Competes_With",
"source_file": "AMGN_10k_2024.pdf",
"page_id": "page_15",
"chunk_id": "chunk_2",
"chunk_text": "| Product | Territory | Competitor-marketed product | Competitors |\n|------------|-----------... |
qualitative_2hop_cross_company-00701 | What specific operational risks do AMD and IBM highlight regarding their reliance on open-source software, and how might these risks impact their respective technology development and product offerings? | AMD highlights that continued use of open-source software and related technologies, such as compilers, is important for the operation of the design tools upon which its customers depend. A disruption in access to such software could hinder AMD's ability to develop and support its semiconductor products, including CPUs,... | [
"Step 1: Extract from AMD's 10-K - AMD has acquired licenses to certain proprietary software, open-source software, and related technologies, such as compilers, for its design tools, and continued use of such software is important to the operation of the design tools upon which its customers depend.",
"Step 2: Ex... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG | inter_document_cross_company | Information Technology | Semiconductors | medium | 4.781921 | 47 | [
{
"role": "start",
"id": "AMD",
"name": "AMD",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Open-Source_Software",
"name": "Open-Source Software",
"type": "PRODUCT",
"year": null,
"idf_score": 4.78192069773259
},
{
"ro... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "AMD_10k_2022.pdf",
"page_id": "page_13",
"chunk_id": "chunk_1",
"chunk_text": "and energy efficiency. HBM memory chips are vertically stacked, like floors in a skyscraper to shorten the distance of the information being communicated. ... |
qualitative_2hop_cross_company-00702 | How do GM and HD differently apply interest rate forward curves in their fair value measurement approaches, and what specific financial impacts did GM report related to fair value hedges in 2024? | GM uses interest rate forward curves as part of the market approach to derive fair value for Level 2 instruments and reported losses of $200 million related to fair value hedges in 2024. HD also uses interest rate forward curves, but as part of an income approach to determine the fair values of its derivative instrumen... | [
"Step 1: From GM's 10-K, we identify that interest rate forward curves are used under the market approach for Level 2 instruments and that GM reported a $200 million loss from fair value hedges in 2024.",
"Step 2: From HD's 10-K, we see that interest rate forward curves are used as Level 2 inputs in an income app... | qualitative | 2 | cross_company | chain | ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Depends_On]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Interest_Rate_Forward_Curves",
"name": "Interest Rate Forward Curves",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.5736801... | [
{
"hop": 1,
"relationship": "Complies_With",
"source_file": "GM_10k_2024.pdf",
"page_id": "page_84",
"chunk_id": "chunk_3",
"chunk_text": "\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) The g ains/losses included in our consolidated income statements and statements of comprehensive inco... |
qualitative_2hop_cross_company-00703 | What is the total fair value of private equity, hedge, and other funds held by JPM at year-end 2023, and how does this compare to the type of fund investments AIG makes commitments to, as disclosed in their respective filings? | JPM disclosed a fair value of $1.0 billion for private equity, hedge, and other funds at year-end 2023. AIG disclosed that it makes investment commitments to private equity funds, hedge funds, and other funds as part of its normal course of business, with the purpose of funding new investments or fund expenses. While b... | [
"Step 1: From JPM’s filing, extract the fair value of private equity, hedge, and other funds at year-end 2023, which is $1.0 billion.",
"Step 2: From AIG’s filing, extract the types of funds AIG commits capital to, which include private equity funds, hedge funds, and other funds.",
"Step 3: Compare the two disc... | qualitative | 2 | cross_company | chain | ORG -[Commits_To]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Financials | Multi-line Insurance | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "AIG",
"name": "AIG",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Other_Funds",
"name": "Other Funds",
"type": "FIN_INST",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Commits_To",
"source_file": "AIG_10k_2023.pdf",
"page_id": "page_111",
"chunk_id": "chunk_3",
"chunk_text": "\n(a) Excludes\tguarantees,\tCMAs\tor\tother\tsupport\tarrangements\tbetween\tAIG\tconsolidated\tentities.\n\n(b) Excludes\tcommitments\twith\trespect\tto... |
qualitative_2hop_cross_company-00704 | How did the change in ownership percentage of Keurig Dr Pepper Inc. by MDLZ in 2023 impact the accounting treatment of the investment, and how does this contrast with KO's competitive positioning against Keurig Dr Pepper Inc. in the beverage industry? | In 2023, MDLZ's ownership in Keurig Dr Pepper Inc. (KDP) fell below 5%, which triggered a change in accounting treatment from equity method investment to marketable securities, as MDLZ no longer had significant influence over KDP. This resulted in the remaining shares being measured at fair value with changes recognize... | [
"Step 1: From MDLZ's 10-K, identify the change in ownership percentage of KDP and the resulting accounting change from equity method to marketable securities.",
"Step 2: Extract the financial impact of MDLZ's KDP share sales, including the number of shares sold, proceeds, and pre-tax gain.",
"Step 3: From KO's ... | qualitative | 2 | cross_company | chain | ORG -[Competes_Against]-> COMP <-[Involved_In]- ORG | inter_document_cross_company | Consumer Staples | Soft Drinks & Non-alcoholic Beverages | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "KO",
"name": "KO",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Keurig_Dr_Pepper_Inc.",
"name": "Keurig Dr Pepper Inc.",
"type": "COMP",
"year": null,
"idf_score": 6.168215058852481
},
{
"role... | [
{
"hop": 1,
"relationship": "Competes_Against",
"source_file": "KO_10k_2023.pdf",
"page_id": "page_9",
"chunk_id": "chunk_1",
"chunk_text": "## Investments\tin\tBottling\tOperations\n\nMost\tof\tour\tbranded\tbeverage\tproducts\tare\tprepared,\tpackaged,\tdistributed\tand\tsold\tby\tindepend... |
qualitative_2hop_cross_company-00705 | How do Abbott and Medtronic's disclosures regarding remote monitoring services help assess their respective deferred revenue liabilities tied to long-term service obligations as of year-end 2023? | Abbott explicitly quantifies its remaining performance obligations tied to remote monitoring services at approximately $478 million in its Medical Devices segment, as disclosed in Note 3 of its 10-K filing. This figure reflects obligations related to remote monitoring services associated with previously implanted devic... | [
"Step 1: Extract from source A - Abbott quantifies remaining performance obligations related to remote monitoring services at $478 million in the Medical Devices segment (Note 3).",
"Step 2: Extract from source B - Medtronic notes that deferred revenue primarily includes remote monitoring services but does not di... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "ABT",
"name": "ABT",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Remote_Monitoring_Services",
"name": "Remote Monitoring Services",
"type": "PRODUCT",
"year": null,
"idf_score": 6.573680166960646
}... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "ABT_10k_2023.pdf",
"page_id": "page_54",
"chunk_id": "chunk_1",
"chunk_text": "## Abbott\tLaboratories\tand\tSubsidiaries\n\n## Notes\tto\tConsolidated\tFinancial\tStatements\t(Continued)\n\n## Note\t3\t-\tRevenue\t(Continued)\n\nAbbo... |
qualitative_2hop_cross_company-00706 | How did the labor agreements at GD and UNP influence their respective operating cost outlooks for 2024, and what does this suggest about the timing and scale of labor cost pressures faced by each company? | GD expected to negotiate 23 labor agreements in 2025 covering approximately 5,400 employees and stated that these renegotiations would not have a material impact on its results of operations, financial condition, or cash flows. In contrast, UNP already experienced the effects of labor agreements in 2024, which contribu... | [
"Step 1: From GD's 2024 10-K, identify the expectation to renegotiate 23 agreements covering 5,400 employees in 2025 and the stated belief that this would not have a material impact.",
"Step 2: From UNP's 2024 10-K, extract the 2% increase in compensation and benefits expenses linked to labor agreements affecting... | qualitative | 2 | cross_company | chain | ORG -[Faces]-> RISK_FACTOR <-[Depends_On]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "GD",
"name": "GD",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Labor_Agreements",
"name": "Labor Agreements",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 5.8805329864007
},
{
"role": "e... | [
{
"hop": 1,
"relationship": "Faces",
"source_file": "GD_10k_2024.pdf",
"page_id": "page_78",
"chunk_id": "chunk_1",
"chunk_text": "price above the fair m arket value at the tim e the new aircraft is delivered is treated as a reduction of revenue in the new-aircraft sales transaction. As of D... |
qualitative_2hop_cross_company-00707 | What specific financial impact did Intel's 2024 Restructuring Plan have on its consolidated results, and how does this compare to Oracle's disclosed approach to restructuring expenses under its own 2024 Restructuring Plan? | Intel's 2024 Restructuring Plan resulted in $2.8 billion of restructuring charges that materially impacted its consolidated results. In contrast, Oracle also implemented a 2024 Restructuring Plan, but its filings only disclose that the expenses were primarily related to employee severance without specifying a dollar am... | [
"Step 1: From Intel's 10-K, identify the specific restructuring charge amount of $2.8 billion related to the 2024 Restructuring Plan.",
"Step 2: From Oracle's 10-K, extract the nature of restructuring expenses under its 2024 plan, which are described as primarily related to employee severance but without a specif... | qualitative | 2 | cross_company | chain | ORG -[Announces]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Information Technology | Semiconductors | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "INTC",
"name": "INTC",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "2024_Restructuring_Plan",
"name": "2024 Restructuring Plan",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.1682150588524... | [
{
"hop": 1,
"relationship": "Announces",
"source_file": "INTC_10k_2024.pdf",
"page_id": "page_15",
"chunk_id": "chunk_1",
"chunk_text": "## Management's Discussion and Analysis\n\n## Overview\n\nWe are a global designer and manufacturer of semiconductor products, including CPUs and other sol... |
qualitative_2hop_cross_company-00708 | How do Altria and Target differ in their disclosure approaches regarding the Code of Business Conduct and Ethics, and what specific governance-related sections are made available to shareholders in each company's 10-K filing? | Altria directly discloses its Code of Business Conduct and Ethics in its 10-K filing and makes it available on its website, specifically stating that it applies to all employees and Board members. In contrast, Target does not directly disclose its Code of Business Conduct and Ethics within the 10-K filing but instead i... | [
"Step 1: From evidence_source_a, Altria directly discloses its 'Altria Code of Conduct for Compliance and Integrity' and states it applies to employees and Board members, with availability on its website.",
"Step 2: From evidence_source_b, Target does not include the Code of Business Conduct and Ethics directly i... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Tobacco | medium | 4.781921 | 47 | [
{
"role": "start",
"id": "MO",
"name": "MO",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Code_of_Business_Conduct_and_Ethics",
"name": "Code of Business Conduct and Ethics",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_sco... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "MO_10k_2022.pdf",
"page_id": "page_113",
"chunk_id": "chunk_3",
"chunk_text": "\nAll of the above-mentioned executive officers have been employed by Altria or its subsidiaries in various capacities during the past five years.\n\nMr. Wh... |
qualitative_2hop_cross_company-00709 | How do Intel's and Oracle's 2024 Restructuring Plans differ in their approaches to cost-saving initiatives, particularly regarding Intel's $14.0 billion capital expenditure commitment for 2025? | Intel's 2024 Restructuring Plan focuses on reducing operating expenditures, capital expenditures, and cost of sales through measures such as headcount reductions, aiming to create capacity for sustained investment in technology and manufacturing competitiveness. This includes a $14.0 billion capital expenditure commitm... | [
"Step 1: From Intel's filing, identify the $14.0 billion capital expenditure commitment for 2025 and its intended use in manufacturing expansion and technology investment as part of the 2024 Restructuring Plan.",
"Step 2: From Oracle's filing, extract the focus of its 2024 Restructuring Plan on improving operatio... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG | inter_document_cross_company | Information Technology | Semiconductors | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "INTC",
"name": "INTC",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "2024_Restructuring_Plan",
"name": "2024 Restructuring Plan",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.1682150588524... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "INTC_10k_2024.pdf",
"page_id": "page_30",
"chunk_id": "chunk_1",
"chunk_text": "## Liquidity and Capital Resources\n\nWe believe we have sufficient sources of funding to meet our business requirements for the next 12 months and in the ... |
qualitative_2hop_cross_company-00710 | How do GM and LOW differ in their use of observable market inputs for determining the fair value of financial instruments, based on the specific methods and classifications described in their respective disclosures? | GM uses observable market inputs such as quoted prices of similar instruments and foreign exchange and interest rate forward curves to derive the fair value for Level 2 instruments. In contrast, LOW uses pricing models based on observable market inputs like benchmark yields, reported trades, broker-dealer quotes, issue... | [
"Step 1: From evidence_source_a, GM uses quoted prices of similar instruments and foreign exchange and interest rate forward curves for Level 2 fair value measurements.",
"Step 2: From evidence_source_b, LOW uses pricing models based on observable inputs such as benchmark yields, reported trades, broker-dealer qu... | qualitative | 2 | cross_company | chain | ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 5.475068 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Observable_Market_Inputs",
"name": "Observable Market Inputs",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.475067878292536... | [
{
"hop": 1,
"relationship": "Complies_With",
"source_file": "GM_10k_2022.pdf",
"page_id": "page_81",
"chunk_id": "chunk_3",
"chunk_text": "\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) The gains/losses included in our consolidated income statements and statements of comprehensive income for the ye... |
qualitative_2hop_cross_company-00711 | How much total unrecognized compensation expense related to performance stock units remains for both GD and UNP combined, and over what average time period is this expense expected to be recognized? | The total unrecognized compensation expense related to performance stock units for GD and UNP combined is $120 million. This expense is expected to be recognized over a weighted average period of 1.9 years for GD and 1.1 years for UNP. | [
"Step 1: From GD's 10-K filing, we find that on December 31, 2024, GD had $105 million of unrecognized compensation cost related to restricted stock and RSUs, which includes PSUs, and this is expected to be recognized over a weighted average period of 1.9 years.",
"Step 2: From UNP's 10-K filing, we find that at ... | qualitative | 2 | cross_company | chain | ORG -[Determines]-> ACCOUNTING_POLICY <-[Subject_To]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | hard | 5.320917 | 47 | [
{
"role": "start",
"id": "GD",
"name": "GD",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Performance_Measures",
"name": "Performance Measures",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.320917198465278
},
... | [
{
"hop": 1,
"relationship": "Determines",
"source_file": "GD_10k_2024.pdf",
"page_id": "page_86",
"chunk_id": "chunk_1",
"chunk_text": "on their restricted shares and are entitled to vote those shares, while RSU recipients receive dividend-equivalent units instead of cash dividends and are n... |
qualitative_2hop_cross_company-00712 | What was the total value of surety bonds held by Altria and its subsidiaries at the end of 2021, and how does this compare to the surety bonds held by Target as of January 29, 2022? | Altria and its subsidiaries had $19 million in surety bonds at the end of 2021, while Target had $517 million in surety bonds as of January 29, 2022. This results in a difference of $498 million between the two companies' surety bond values. | [
"Step 1: Extract from source MO_10k_2022.pdf - Altria had $19 million in surety bonds recorded on its consolidated balance sheet as of December 31, 2021.",
"Step 2: Extract from source TGT_10k_2022.pdf - Target had $517 million in surety bonds as of January 29, 2022.",
"Step 3: Calculate the difference between ... | qualitative | 2 | cross_company | chain | ORG -[Guarantees]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Tobacco | medium | 4.494239 | 47 | [
{
"role": "start",
"id": "MO",
"name": "MO",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Surety_Bonds",
"name": "Surety Bonds",
"type": "FIN_INST",
"year": null,
"idf_score": 4.4942386252808095
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Guarantees",
"source_file": "MO_10k_2022.pdf",
"page_id": "page_108",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nAltria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are p... |
qualitative_2hop_cross_company-00713 | How do U.S. laws subject both General Dynamics (GD) and Union Pacific (UNP) to material adverse effects on their operations, and what specific obligations under these laws create compliance risks for each company? | U.S. laws subject both General Dynamics and Union Pacific to material compliance risks that could lead to penalties or operational disruptions. General Dynamics must comply with U.S. and foreign laws including the Foreign Corrupt Practices Act (FCPA), export controls, and the International Traffic in Arms Regulations (... | [
"Step 1: From evidence_source_a, GD is subject to U.S. and foreign laws including the FCPA, ITAR, and export controls, and failure to comply could lead to administrative, civil, or criminal liabilities, including suspension from government contracts or loss of export privileges.",
"Step 2: From evidence_source_b,... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | medium | 4.494239 | 47 | [
{
"role": "start",
"id": "GD",
"name": "GD",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "U.S._Laws",
"name": "U.S. Laws",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 4.4942386252808095
},
{
"role": "e... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "GD_10k_2024.pdf",
"page_id": "page_23",
"chunk_id": "chunk_1",
"chunk_text": "cost-effective prices. Many of our new products m ust m eet extensive and tim e-consum ing regulatory requirem ents that are often outside our control and m... |
qualitative_2hop_cross_company-00714 | How does Adobe's reliance on ISVs for deploying Experience Cloud solutions compare with NVIDIA's use of ISVs in promoting its AI and accelerated computing platforms, and what specific ecosystem initiatives do both companies employ to support these partnerships? | Adobe utilizes an extensive ecosystem of partners, including ISVs, to license and deploy its Experience Cloud solutions, enhancing market reach and customer adoption. Similarly, NVIDIA incorporates ISVs into its partner network to promote the development of applications optimized for its GPU and AI platforms. Adobe str... | [
"Step 1: Extract from source A - Adobe utilizes an extensive ecosystem of partners, including ISVs, to license and deploy Experience Cloud solutions, with strategic partnerships such as Microsoft, IBM, Fluent Commerce, and Dentsu.",
"Step 2: Extract from source B - NVIDIA incorporates ISVs into its global partner... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Information Technology | Application Software | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "ADBE",
"name": "ADBE",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "ISVs",
"name": "ISVs",
"type": "COMP",
"year": null,
"idf_score": 5.8805329864007
},
{
"role": "end",
"id": "NVDA",
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "ADBE_10k_2022.pdf",
"page_id": "page_8",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\na large and growing opportunity and we are in position to help businesses and enterprises invest in solutions that aid their goals ... |
qualitative_2hop_cross_company-00715 | Which consumer packaged goods companies are common competitors to both Colgate-Palmolive and Mondelēz International based on their 2023 peer group disclosures? | The consumer packaged goods companies that are common competitors to both Colgate-Palmolive and Mondelēz International in their 2023 peer groups are The Coca-Cola Company, General Mills, Inc., The Kraft Heinz Company, PepsiCo, Inc., The Procter & Gamble Company, and Unilever PLC. | [
"Step 1: From Colgate-Palmolive's 2023 10-K filing, extract the list of companies in its new peer group for 2023, which includes consumer products companies with significant presence in oral care, personal care, and/or home care.",
"Step 2: From Mondelēz International's 2023 10-K filing, extract the list of compa... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Unilever_PLC",
"name": "Unilever PLC",
"type": "COMP",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
"id"... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2023.pdf",
"page_id": "page_126",
"chunk_id": "chunk_1",
"chunk_text": "## Market\tInformation\n\nThe\tCompany's\tcommon\tstock\tis\tlisted\ton\tthe\tNew\tYork\tStock\tExchange,\tand\tits\ttrading\tsymbol\tis\tCL.\n\n## Stock\tP... |
qualitative_2hop_cross_company-00716 | What is the difference in the percentage of revenue recognized over time between GD's defense segments and RTX's Raytheon Intelligence & Space and Raytheon Missiles & Defense segments in 2021? | The difference in the percentage of revenue recognized over time between GD's defense segments and RTX's Raytheon Intelligence & Space and Raytheon Missiles & Defense segments in 2021 is 0%, as both companies recognized 100% of their revenue from these segments over time. | [
"Step 1: Extract from source A - GD's defense segments recognize substantially all revenue over time, with 78% of total revenue recognized over time in 2021.",
"Step 2: Extract from source B - RTX's Raytheon Intelligence & Space and Raytheon Missiles & Defense segments recognize substantially all revenue over tim... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "GD",
"name": "GD",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Contract_Estimates",
"name": "Contract Estimates",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.168215058852481
},
{
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "GD_10k_2022.pdf",
"page_id": "page_61",
"chunk_id": "chunk_1",
"chunk_text": "Our performance obligations are satisfied over time as work progresses or at a point in time. Revenue from products and services transferred to customers ove... |
qualitative_2hop_cross_company-00717 | What is the difference in the initial fixed dividend rates between COF's Series I preferred stock issued in 2019 and SCHW's Series I preferred stock issued in 2021, and how frequently are dividends paid for each? | COF's Series I preferred stock has an initial fixed dividend rate of 5.000%, while SCHW's Series I preferred stock has an initial fixed dividend rate of 4.375%. The difference between these rates is 0.625%. Both companies pay dividends quarterly for their respective Series I preferred stocks. | [
"Step 1: From COF's filing, identify the dividend rate for Series I preferred stock - 5.000% as stated in the table from evidence_source_a.",
"Step 2: From SCHW's filing, identify the dividend rate for Series I preferred stock - 4.375% as stated in evidence_source_b.",
"Step 3: Calculate the difference between ... | qualitative | 2 | cross_company | chain | ORG -[Introduces]-> FIN_INST <-[Issues]- ORG | inter_document_cross_company | Financials | Consumer Finance | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "COF",
"name": "COF",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Series_I",
"name": "Series I",
"type": "FIN_INST",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
"id": ... | [
{
"hop": 1,
"relationship": "Introduces",
"source_file": "COF_10k_2023.pdf",
"page_id": "page_83",
"chunk_id": "chunk_2",
"chunk_text": "| | | | Per Annum ... |
qualitative_2hop_cross_company-00718 | How does the creditworthiness monitoring strategy of AbbVie, as it relates to its healthcare receivables, align with or differ from Medtronic's approach in mitigating risks associated with trade receivables tied to national healthcare systems? | Both AbbVie and Medtronic actively monitor the creditworthiness of their customers to mitigate the risk of non-payment of trade receivables. AbbVie specifically establishes an allowance for credit losses based on estimates of future losses over the contractual life of outstanding accounts receivable and communicates re... | [
"Step 1: Extract from source A - AbbVie establishes an allowance for credit losses equal to the estimate of future losses over the contractual life of outstanding accounts receivable and communicates with customers regarding payment plans.",
"Step 2: Extract from source B - Medtronic notes that repayment of trade... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> RISK_FACTOR <-[Discloses]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "ABBV",
"name": "ABBV",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Creditworthiness_of_Customers",
"name": "Creditworthiness of Customers",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.1682150... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "ABBV_10k_2022.pdf",
"page_id": "page_68",
"chunk_id": "chunk_1",
"chunk_text": "No commercial paper borrowings were issued during 2021. In 2020, the company issued and redeemed commercial paper. There were no commercial paper borrowi... |
qualitative_2hop_cross_company-00719 | How do Adobe and NVIDIA leverage their relationships with Independent Software Vendors (ISVs) to enhance their respective software distribution and platform adoption strategies? | Adobe utilizes its ISV relationships as part of its distribution network to deliver products and services to end users, enabling broader market reach beyond direct sales and app stores. This distribution strategy allows Adobe to integrate its software into various third-party solutions and ensures availability across m... | [
"Step 1: Extract from evidence_source_a - Adobe distributes products through ISVs, which are part of its broader network that includes VARs, SIs, OEMs, and retailers.",
"Step 2: Extract from evidence_source_b - NVIDIA works with ISVs as part of its global partner network to support platform adoption and integrati... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Information Technology | Application Software | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "ADBE",
"name": "ADBE",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "ISVs",
"name": "ISVs",
"type": "COMP",
"year": null,
"idf_score": 5.8805329864007
},
{
"role": "end",
"id": "NVDA",
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "ADBE_10k_2022.pdf",
"page_id": "page_62",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## ADOBE INC.\n\n## NOTES TO CONSOLIDATED FINANCIAL STATEMENTS\n\n## NOTE 1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POL... |
qualitative_2hop_cross_company-00720 | How many companies are common between Colgate-Palmolive's 2023 New Peer Group and Mondelēz International's 2023 performance peer group, based on the specific companies listed in each group? | There are 8 companies common between Colgate-Palmolive's 2023 New Peer Group and Mondelēz International's 2023 performance peer group. | [
"Step 1: From Colgate-Palmolive's 2023 New Peer Group list, extract all companies mentioned: Church & Dwight Co., Inc., The Clorox Company, The Coca-Cola Company, The Estee Lauder Companies, Inc., General Mills, Inc., Haleon plc, Kellanova, Kenvue Inc., Kimberly-Clark Corporation, The Kraft Heinz Company, PepsiCo, ... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "General_Mills,_Inc.",
"name": "General Mills, Inc.",
"type": "COMP",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2023.pdf",
"page_id": "page_126",
"chunk_id": "chunk_1",
"chunk_text": "## Market\tInformation\n\nThe\tCompany's\tcommon\tstock\tis\tlisted\ton\tthe\tNew\tYork\tStock\tExchange,\tand\tits\ttrading\tsymbol\tis\tCL.\n\n## Stock\tP... |
qualitative_2hop_cross_company-00721 | Given that both General Dynamics and Raytheon use cost-based methods for recognizing revenue on long-term defense contracts, how does the scale of Raytheon's $64.4 billion in contract revenue impact the financial comparability between the two companies, considering the inherent subjectivity in estimating total costs at... | Raytheon’s $64.4 billion in contract revenue, recognized primarily over time using cost-based progress measures, introduces a significant level of estimation subjectivity due to variables such as labor productivity, subcontractor performance, and funding availability. General Dynamics similarly relies on cost-to-cost m... | [
"Step 1: Extract from source A - General Dynamics employs cost-to-cost methods for long-term defense contracts and recognizes that estimation changes can materially affect profitability.",
"Step 2: Extract from source B - Raytheon recognizes $64.4 billion in contract revenue using similar cost-based progress meas... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Relies_On]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "GD",
"name": "GD",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Contract_Estimates",
"name": "Contract Estimates",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.168215058852481
},
{
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "GD_10k_2022.pdf",
"page_id": "page_48",
"chunk_id": "chunk_1",
"chunk_text": "assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the repor... |
qualitative_2hop_cross_company-00722 | What is the total number of Supplemental Indentures involving Elavon Financial Services DAC as a named party in both AbbVie Inc.'s and Medtronic plc's 2022 10-K filings? | The total number of Supplemental Indentures involving Elavon Financial Services DAC as a named party in both AbbVie Inc.'s and Medtronic plc's 2022 10-K filings is 5. | [
"Step 1: From AbbVie Inc.'s 2022 10-K filing, Exhibit 4.6 specifically names Elavon Financial Services DAC as the transfer agent and registrar in Supplemental Indenture No. 4, dated November 17, 2016.",
"Step 2: From Medtronic plc's 2022 10-K filing, Elavon Financial Services DAC is named in multiple indentures: ... | qualitative | 2 | cross_company | chain | ORG -[Partners_With]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "ABBV",
"name": "ABBV",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Elavon_Financial_Services_DAC",
"name": "Elavon Financial Services DAC",
"type": "COMP",
"year": null,
"idf_score": 6.16821505885248... | [
{
"hop": 1,
"relationship": "Partners_With",
"source_file": "ABBV_10k_2022.pdf",
"page_id": "page_151",
"chunk_id": "chunk_1",
"chunk_text": "## PART IV\n\n## ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES\n\n- (a) Documents filed as part of this Form 10-K.\n- (1) Financial Statements: See... |
qualitative_2hop_cross_company-00723 | What is the total value of NVDA's derivative instruments as of January 30, 2022, and how does this compare to the notional amount of ADBE's outstanding cash flow hedges as of December 3, 2021? | The total value of NVDA's derivative instruments as of January 30, 2022, is $1,431 million ($1,023 million designated as cash flow hedges + $408 million non-designated hedges). This compares to $2.06 billion as of December 3, 2021, for ADBE's outstanding cash flow hedges. This means ADBE's cash flow hedges are signific... | [
"Step 1: Extract NVDA's designated cash flow hedges value of $1,023 million as of January 30, 2022, from the NVDA filing.",
"Step 2: Extract NVDA's non-designated hedges value of $408 million as of January 30, 2022, from the NVDA filing.",
"Step 3: Calculate NVDA's total derivative instruments by summing design... | qualitative | 2 | cross_company | chain | ORG -[Has]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Information Technology | Application Software | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "ADBE",
"name": "ADBE",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Non-Designated_Hedges",
"name": "Non-Designated Hedges",
"type": "FIN_INST",
"year": null,
"idf_score": 5.657389435086491
},
{
... | [
{
"hop": 1,
"relationship": "Has",
"source_file": "ADBE_10k_2022.pdf",
"page_id": "page_79",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## ADOBE INC.\n\n## NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)\n\n## NOTE 6. DERIVATIVE FINANCIAL INSTRUMENTS\n\nWe may use ... |
qualitative_2hop_cross_company-00724 | Lockheed Martin's Space segment derived approximately 6% of its 2021 operating profit from equity method investees, including United Launch Alliance. Given Caterpillar's explicit warning about the risks of anti-corruption violations by joint venture partners, what specific financial risk does Lockheed Martin face throu... | Lockheed Martin faces the risk that anti-corruption violations by its equity method investees, such as United Launch Alliance, could result in severe penalties, legal costs, or reputational damage. Since the Space segment derived approximately 6% of its 2021 operating profit from these investees, any disruption or fina... | [
"Step 1: Extract from evidence_source_b - Lockheed Martin's Space segment derived approximately 6% of its 2021 operating profit from equity method investees, primarily United Launch Alliance.",
"Step 2: Extract from evidence_source_a - Caterpillar explicitly warns that anti-corruption violations by joint venture ... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG | inter_document_cross_company | Industrials | Construction Machinery & Heavy Transportation Equipment | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "CAT",
"name": "CAT",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Anti-Corruption_Violations",
"name": "Anti-Corruption Violations",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.168215058852481... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "CAT_10k_2022.pdf",
"page_id": "page_24",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nIn addition, the U.S. Foreign Corrupt Practices Act and similar foreign anti-corruption laws generally prohibit companies and thei... |
qualitative_2hop_cross_company-00725 | How much in tax savings did PayPal (PYPL) benefit from its Luxembourg-based tax agreements before they expired at the end of 2019, and what role did Luxembourg play in BNY Mellon's (BK) international operations as of 2022? | PayPal benefited from Luxembourg-based tax agreements before their expiration at the end of 2019, which contributed to a total tax savings of $472 million in 2019. Luxembourg also played a role in BNY Mellon's international operations as of 2022, as it was one of the locations where BNY Mellon SA/NV operated through a ... | [
"Step 1: Extract from source A - BNY Mellon SA/NV operates in Luxembourg through a branch office and engages in global custody, asset servicing, and collateral management.",
"Step 2: Extract from source B - PayPal had Luxembourg-based tax agreements that expired at the end of 2019, resulting in $472 million in ta... | qualitative | 2 | cross_company | chain | ORG -[Operates_In]-> GPE <-[Operates_In]- ORG | inter_document_cross_company | Financials | Asset Management & Custody Banks | medium | 4.868932 | 47 | [
{
"role": "start",
"id": "BK",
"name": "BK",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Luxembourg",
"name": "Luxembourg",
"type": "GPE",
"year": null,
"idf_score": 4.8689320747222204
},
{
"role": "end",
"id": "P... | [
{
"hop": 1,
"relationship": "Operates_In",
"source_file": "BK_10k_2022.pdf",
"page_id": "page_6",
"chunk_id": "chunk_1",
"chunk_text": "## ITEM 1. BUSINESS\n\n## Description of Business\n\nThe Bank of New York Mellon Corporation, a Delaware corporation (NYSE symbol: BK), is a global company ... |
qualitative_2hop_cross_company-00726 | How does the implementation of the Medical Device Regulation (MDR) in the European Union affect both AbbVie and Medtronic's ability to market their Class III medical devices, and by how many years was the transition period provided under the MDR for devices with valid CE certificates issued under the previous directive... | The implementation of the Medical Device Regulation (MDR) in the European Union imposes significant additional pre-market and post-market requirements on both AbbVie and Medtronic, affecting their ability to market Class III medical devices. AbbVie, which includes breast implants classified as Class III devices, must c... | [
"Step 1: Extract from source A - AbbVie's breast implants are classified as Class III medical devices and are subject to the MDR in the European Union.",
"Step 2: Extract from source B - Medtronic states that devices with valid CE certificates issued under the previous directives before May 2020 can be placed on ... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "ABBV",
"name": "ABBV",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "MDR",
"name": "MDR",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.8805329864007
},
{
"role": "end",
"i... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "ABBV_10k_2022.pdf",
"page_id": "page_24",
"chunk_id": "chunk_1",
"chunk_text": "## Regulation - Medical Devices\n\nMedical devices are subject to regulation by the FDA, state agencies and foreign government health authorities. FDA reg... |
qualitative_2hop_cross_company-00727 | How many companies were listed in both Colgate-Palmolive's and Mondelēz International's peer groups in 2023, and what percentage of each peer group did this overlap represent? | There were 9 companies listed in both Colgate-Palmolive's and Mondelēz International's peer groups in 2023. This overlap represented approximately 52.9% of Colgate-Palmolive’s 17-company peer group and 69.2% of Mondelēz International’s 13-company peer group. | [
"Step 1: Extract from source A - Colgate-Palmolive’s 2023 peer group consisted of 17 companies, including Kellanova, The Coca-Cola Company, General Mills, Inc., The Kraft Heinz Company, PepsiCo, Inc., The Procter & Gamble Company, Unilever PLC, The Clorox Company, Kimberly-Clark Corporation, and Haleon plc.",
"St... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Kellanova",
"name": "Kellanova",
"type": "COMP",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": "MDL... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2023.pdf",
"page_id": "page_126",
"chunk_id": "chunk_1",
"chunk_text": "## Market\tInformation\n\nThe\tCompany's\tcommon\tstock\tis\tlisted\ton\tthe\tNew\tYork\tStock\tExchange,\tand\tits\ttrading\tsymbol\tis\tCL.\n\n## Stock\tP... |
qualitative_2hop_cross_company-00728 | How does the reliance on trade secret protection as a critical competitive factor influence both Amazon's and Starbucks' strategies for maintaining their market positions, and what specific intellectual property risks do they each highlight in their filings that could threaten these strategies? | Both Amazon and Starbucks identify intellectual property, including trade secrets, as critical to their competitive advantage. Amazon emphasizes that its trademarks, patents, and trade secrets are essential to its success and that it uses legal protections and confidentiality agreements to safeguard these assets. Howev... | [
"Step 1: Extract from evidence_source_a - Amazon relies on trade secrets, patents, and trademarks as critical to its success and uses legal protections and confidentiality agreements to safeguard these assets.",
"Step 2: Extract from evidence_source_b - Starbucks relies on trademarks, service marks, trade secrets... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG | inter_document_cross_company | Consumer Discretionary | Broadline Retail | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "AMZN",
"name": "AMZN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Trade_Secret_Protection",
"name": "Trade Secret Protection",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.06960277... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "AMZN_10k_2023.pdf",
"page_id": "page_4",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## Competition\n\nOur\tbusinesses\tencompass\ta\tlarge\tvariety\tof\tproduct\ttypes,\tservice\tofferings,\tand\tdelivery\tchannel... |
qualitative_2hop_cross_company-00729 | How does the competitive pricing pressure described in both Medtronic's and Merck's 10-K filings influence their respective exposure to financial risk in international markets? | Medtronic identifies 'decreasing selling prices and pricing pressure' as a material risk factor that could materially affect its business operations and financial results. This aligns with Merck's detailed description of competitive pricing pressure in the European Union, where the company faces downward pricing pressu... | [
"Step 1: Extract from source A - Medtronic (MDT) identifies 'decreasing selling prices and pricing pressure' as a material risk factor.",
"Step 2: Extract from source B - Merck (MRK) faces competitive pricing pressure in the EU due to generic/biosimilar competition, reference pricing, and HTA requirements.",
"S... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "MDT",
"name": "MDT",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Competitive_Pricing_Pressure",
"name": "Competitive Pricing Pressure",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.16821505885... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "MDT_10k_2023.pdf",
"page_id": "page_5",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n- self-insurance,\n- commercial\tinsurance,\n- changes\tin\tapplicable\ttax\trates,\n- positions\ttaken\tby\ttaxing\tauthorities,... |
qualitative_2hop_cross_company-00730 | How do IBM's and NVIDIA's approaches to credit evaluations differ in terms of their financial impact on each company's income statement when credit losses occur? | IBM adjusts its allowance for credit losses, which directly affects its consolidated net income in the period the adjustments are made, particularly when dealing with major customers or unexpected default rates. In contrast, NVIDIA recognizes allowances for credit losses and write-downs in the 'other income (expense), ... | [
"Step 1: Extract from source A - IBM performs ongoing credit evaluations of its clients' financial conditions and adjusts its allowance for credit losses, which could affect its consolidated net income.",
"Step 2: Extract from source B - NVIDIA recognizes allowances for credit losses and write-downs in the 'other... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Information Technology | IT Consulting & Other Services | hard | 5.187386 | 47 | [
{
"role": "start",
"id": "IBM",
"name": "IBM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Credit_Evaluations",
"name": "Credit Evaluations",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.187385805840755
},
{
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "IBM_10k_2023.pdf",
"page_id": "page_11",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\nthe\tcompany's\tsales\tare\ton\tan\topen\tcredit\tbasis,\tand\tthe\tcompany\tperforms\tongoing\tcredit\tevaluations\tof\tits\tcli... |
qualitative_2hop_cross_company-00731 | What is the total fair value of Level 1 marketable equity securities held by Starbucks (SBUX) and how does this compare to Amazon's (AMZN) fair value of equity warrants, which are partially classified as Level 2 and Level 3 assets? | Starbucks holds $69.6 million in marketable equity securities categorized as Level 1 assets, while Amazon holds equity warrants valued at $2.2 billion as of December 31, 2023, which are partially classified as Level 2 and Level 3 assets. Amazon's equity warrants are significantly higher in value compared to Starbucks' ... | [
"Step 1: From evidence_source_b, Starbucks reports the fair value of its marketable equity securities as $69.6 million, categorized entirely under Level 1.",
"Step 2: From evidence_source_a, Amazon reports equity warrants with a fair value of $2.2 billion as of December 31, 2023, classified as Level 2 and Level 3... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Consumer Discretionary | Broadline Retail | medium | 4.222305 | 47 | [
{
"role": "start",
"id": "AMZN",
"name": "AMZN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Marketable_Equity_Securities",
"name": "Marketable Equity Securities",
"type": "FIN_INST",
"year": null,
"idf_score": 4.222304909797... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "AMZN_10k_2023.pdf",
"page_id": "page_47",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## Fair\tValue\tof\tFinancial\tInstruments\n\nFair\tvalue\tis\tdefined\tas\tthe\tprice\tthat\twould\tbe\treceived\tto\tsell\tan\t... |
qualitative_2hop_cross_company-00732 | How do CAT and LMT account for lease extension options in their financial statements, and what specific criteria do they use to determine whether to include these options in the lease term? | CAT includes lease extension options in the recognition of right-of-use assets and lease liabilities when it is reasonably certain that the company will exercise the option. Similarly, LMT includes options to extend leases in the ROU operating lease asset and liability when it is reasonably certain that the company wil... | [
"Step 1: From CAT's 10-K filing, we learn that the company includes lease extension options in the recognition of right-of-use assets and lease liabilities when it is 'reasonably certain' that the option will be exercised.",
"Step 2: From LMT's 10-K filing, we see that the company follows a similar approach, inco... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG | inter_document_cross_company | Industrials | Construction Machinery & Heavy Transportation Equipment | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "CAT",
"name": "CAT",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Extension_Options",
"name": "Extension Options",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.069602770184371
},
{
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CAT_10k_2022.pdf",
"page_id": "page_126",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nTrade receivables are primarily short-term receivables from independently owned and operated dealers and customers which arise in t... |
qualitative_2hop_cross_company-00733 | What specific entities within JPMorgan Chase are listed as Administrative Agents in PayPal's credit agreement, and how does this financial partnership contrast with BNY Mellon's competitive relationship with JPMorgan Chase in the provision of financial services? | JPMorgan Chase Bank, N.A., J.P. Morgan Securities Australia Limited, J.P. Morgan Europe Limited, and JPMorgan Chase Bank, N.A., Toronto Branch are listed as Administrative Agents in PayPal's credit agreement. This indicates a financial services partnership between PayPal and these JPMorgan Chase entities, where JPMorga... | [
"Step 1: Extract from evidence_source_b - Identify the specific JPMorgan Chase entities listed as Administrative Agents in PayPal's credit agreement (JPMorgan Chase Bank, N.A., J.P. Morgan Securities Australia Limited, J.P. Morgan Europe Limited, and JPMorgan Chase Bank, N.A., Toronto Branch).",
"Step 2: Extract ... | qualitative | 2 | cross_company | chain | ORG -[Competes_With]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Financials | Asset Management & Custody Banks | medium | 4.008731 | 47 | [
{
"role": "start",
"id": "BK",
"name": "BK",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "JPMorgan_Chase",
"name": "JPMorgan Chase",
"type": "COMP",
"year": null,
"idf_score": 4.0087308094991085
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Competes_With",
"source_file": "BK_10k_2022.pdf",
"page_id": "page_7",
"chunk_id": "chunk_1",
"chunk_text": "## Primary Subsidiaries\n\nExhibit 21.1 to this Form 10-K presents a list of BNY Mellon's primary subsidiaries as of Dec. 31, 2021.\n\n## Human Capital Ma... |
qualitative_2hop_cross_company-00734 | What is the difference in the fiscal year-end dates used by Medtronic plc and Merck & Co., Inc. for their 2023 audits of internal control over financial reporting, and how does each company describe the framework used to evaluate the effectiveness of those controls? | Medtronic plc used April 26, 2024, as the fiscal year-end date for its 2023 audit of internal control over financial reporting, while Merck & Co., Inc. used December 31, 2023. Both companies evaluated the effectiveness of their internal controls using the Internal Control - Integrated Framework (2013) issued by the Com... | [
"Step 1: Extract from source A - Medtronic plc's audit of internal control over financial reporting was conducted as of April 26, 2024, and based on COSO's Internal Control - Integrated Framework (2013).",
"Step 2: Extract from source B - Merck & Co., Inc.'s audit of internal control over financial reporting was ... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "MDT",
"name": "MDT",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Understanding_of_Internal_Control",
"name": "Understanding of Internal Control",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "MDT_10k_2023.pdf",
"page_id": "page_53",
"chunk_id": "chunk_1",
"chunk_text": "## Item\t8.\tFinancial\tStatements\tand\tSupplementary\tData\n\n## Report\tof\tIndependent\tRegistered\tPublic\tAccounting\tFirm\n\nTo\tthe\tBoard\tof\tDire... |
qualitative_2hop_cross_company-00735 | What is the difference in the estimated return liabilities between Target and Walmart for their respective fiscal years ending 2024, based on the figures explicitly stated in their 10-K filings? | The difference in estimated return liabilities between Target and Walmart is $12 million, with Target reporting $172 million and Walmart reporting $160 million as of their respective fiscal years ending 2024. | [
"Step 1: Extract from Target's 10-K - The estimated return liability as of February 1, 2025, was $172 million.",
"Step 2: Extract from Walmart's 10-K - The estimated return liability as of the end of fiscal year 2024 was $160 million.",
"Step 3: Calculate the difference - $172 million (Target) minus $160 millio... | qualitative | 2 | cross_company | chain | ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG | inter_document_cross_company | Consumer Staples | Consumer Staples Merchandise Retail | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "TGT",
"name": "TGT",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Grocery",
"name": "Grocery",
"type": "PRODUCT",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": "WM... | [
{
"hop": 1,
"relationship": "Produces",
"source_file": "TGT_10k_2024.pdf",
"page_id": "page_49",
"chunk_id": "chunk_3",
"chunk_text": "\nIncludes apparel for women, men, young adults, kids, toddlers, and babies, as well as jewelry, accessories, and shoes. (a)\n\nIncludes skin and bath care, ... |
qualitative_2hop_cross_company-00736 | What is the combined market value of common stock held by non-affiliates for both BK and PYPL as of June 30, 2021? | $386.4 billion | [
"Step 1: Extract from source A - BK's market value of common stock held by non-affiliates as of June 30, 2021, was $44,195,604,602.",
"Step 2: Extract from source B - PYPL's market value of common stock held by non-affiliates as of June 30, 2021, was approximately $342.2 billion.",
"Step 3: Synthesize - Add the... | qualitative | 2 | cross_company | chain | ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Financials | Asset Management & Custody Banks | easy | 3.801091 | 47 | [
{
"role": "start",
"id": "BK",
"name": "BK",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Large_Accelerated_Filer",
"name": "Large Accelerated Filer",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 3.801091444720... | [
{
"hop": 1,
"relationship": "Complies_With",
"source_file": "BK_10k_2022.pdf",
"page_id": "page_1",
"chunk_id": "chunk_3",
"chunk_text": "\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check ... |
qualitative_2hop_cross_company-00737 | How did the impact of regulatory approval delays on Merck's IPR&D impairments in 2023 compare to the risks Medtronic disclosed regarding delays in regulatory approvals, particularly in terms of financial consequences and asset valuation adjustments? | Merck recorded a $779 million IPR&D impairment charge in 2023 due to the FDA's second Complete Response Letter for gefapixant, which indicated that the drug did not meet substantial evidence of effectiveness. This impairment was directly tied to regulatory delays and the resulting revised market launch plans, which low... | [
"Step 1: Extract from source A - Medtronic disclosed that delays in regulatory approvals are a material risk factor that could affect its business strategy, product development, and financial performance.",
"Step 2: Extract from source B - Merck recorded a $779 million IPR&D impairment charge in 2023 due to the F... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> RISK_FACTOR <-[Impacted_By]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | hard | 5.320917 | 47 | [
{
"role": "start",
"id": "MDT",
"name": "MDT",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Approval_Delays",
"name": "Approval Delays",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 5.320917198465278
},
{
"role": ... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "MDT_10k_2023.pdf",
"page_id": "page_4",
"chunk_id": "chunk_1",
"chunk_text": "## CAUTIONARY\tNOTE\tREGARDING\tFORWARD-LOOKING\tSTATEMENTS\n\nThis\tAnnual\tReport\ton\tForm\t10-K,\tand\tother\twritten\treports\tof\tMedtronic\tplc,\torga... |
qualitative_2hop_cross_company-00738 | How does the retirement of 22 Boeing 757-200 aircraft by Federal Express impact Honeywell's Aerospace business, given Honeywell's stated risk exposure to aircraft retirement trends? | The retirement of 22 Boeing 757-200 aircraft by Federal Express directly aligns with Honeywell's stated risk exposure in its Aerospace business, which notes that aircraft retirements can reduce demand for aftermarket parts and services. Since Honeywell identifies aircraft retirement as a factor that may adversely affec... | [
"Step 1: Extract from source A - Federal Express announced the permanent retirement of 22 Boeing 757-200 aircraft as part of its fleet modernization strategy.",
"Step 2: Extract from source B - Honeywell identifies that aircraft retirements are a risk factor that can reduce demand for aftermarket parts and servic... | qualitative | 2 | cross_company | chain | ORG -[Announces]-> RISK_FACTOR <-[Impacted_By]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Aircraft_Retirement",
"name": "Aircraft Retirement",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.168215058852481
},
{
... | [
{
"hop": 1,
"relationship": "Announces",
"source_file": "FDX_10k_2024.pdf",
"page_id": "page_42",
"chunk_id": "chunk_3",
"chunk_text": "\n(1) Includes one aircraft not currently in operation and undergoing pre-service modifications.\n\n(2) Includes two aircraft not currently in operation and... |
qualitative_2hop_cross_company-00739 | How does Cisco's position as a supplier of collaboration tools compare with Microsoft's focus on developing and integrating its own collaboration applications, particularly in terms of their respective strategic goals and product offerings? | Cisco supplies collaboration tools such as Webex, which is a key part of its portfolio for enabling hybrid work environments. Microsoft, on the other hand, develops and integrates a comprehensive suite of collaboration tools including Microsoft Teams, Microsoft Viva, and Microsoft 365, which are central to its strategy... | [
"Step 1: From evidence_source_a, Cisco is identified as a supplier of collaboration tools, specifically mentioning its Webex platform as central to hybrid work environments.",
"Step 2: From evidence_source_b, Microsoft's strategic ambition includes reinventing productivity and business processes, with collaborati... | qualitative | 2 | cross_company | chain | ORG -[Supplies]-> PRODUCT <-[Depends_On]- ORG | inter_document_cross_company | Information Technology | Communications Equipment | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "CSCO",
"name": "CSCO",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Collaboration_Tools",
"name": "Collaboration Tools",
"type": "PRODUCT",
"year": null,
"idf_score": 5.657389435086491
},
{
"r... | [
{
"hop": 1,
"relationship": "Supplies",
"source_file": "CSCO_10k_2022.pdf",
"page_id": "page_86",
"chunk_id": "chunk_6",
"chunk_text": "\n"
},
{
"hop": 2,
"relationship": "Depends_On",
"source_file": "MSFT_10k_2022.pdf",
"page_id": "page_4",
"chunk_id": "chunk_1",
... |
qualitative_2hop_cross_company-00740 | How do the risks posed by international trade quotas and related restrictions specifically affect HD's supply chain operations and NKE's manufacturing concentration, given that NKE's top five contract manufacturers account for 51% of Nike Brand apparel production and HD explicitly cites quotas as a potential disruption... | The risks posed by international trade quotas and related restrictions have distinct but interconnected implications for both HD and NKE. For HD, the presence of quotas and import-related taxes could disrupt inventory availability by delaying the receipt and delivery of merchandise, impairing the ability to meet custom... | [
"Step 1: Extract from source A - HD cites that quotas and import-related taxes are among the factors that could disrupt its supply chain, impair inventory delivery, and increase costs.",
"Step 2: Extract from source B - NKE's top five contract manufacturers account for 51% of Nike Brand apparel production, indica... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG | inter_document_cross_company | Consumer Discretionary | Home Improvement Retail | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "HD",
"name": "HD",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Quotas",
"name": "Quotas",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.069602770184371
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "HD_10k_2024.pdf",
"page_id": "page_18",
"chunk_id": "chunk_1",
"chunk_text": "## Table of C ontents\n\ninfrastructure, which could significantly disrupt our operations or impair data security; impact our ability to operate or access ... |
qualitative_2hop_cross_company-00741 | How would a uniform 10% strengthening of the U.S. dollar relative to foreign currencies affect FDX's and HON's operating income, based on their respective foreign currency exchange rate risk disclosures? | A uniform 10% strengthening of the U.S. dollar would decrease FDX’s expected operating income by approximately $400 million for 2025. HON also has exposure to foreign currency exchange rate fluctuations, as it uses derivative instruments to reduce risks from such fluctuations, but HON does not quantify the specific ope... | [
"Step 1: From FDX’s 10-K, identify the quantified impact of a 10% strengthening of the U.S. dollar on operating income: $400 million decrease in 2025.",
"Step 2: From HON’s 10-K, confirm the existence of foreign currency exchange rate risk and the use of derivative instruments to mitigate it, but note that no spe... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> RISK_FACTOR <-[Reduces]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Foreign_Currency_Exchange_Rate_Risks",
"name": "Foreign Currency Exchange Rate Risks",
"type": "RISK_FACTOR",
"year": null,
"idf_score... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "FDX_10k_2024.pdf",
"page_id": "page_74",
"chunk_id": "chunk_1",
"chunk_text": "Despite the inherent complexity in the accounting and disclosure of contingencies, we believe that our processes are robust and thorough and provide a consi... |
qualitative_2hop_cross_company-00742 | How does the mention of geopolitical unrest as a risk factor in BlackRock's 2024 10-K compare with Charles Schwab's characterization of the broader economic environment, particularly in relation to their respective financial outlooks and risk management strategies? | BlackRock identifies geopolitical unrest as a specific risk factor that could adversely affect the general economy, domestic and local financial and capital markets, specific industries, or BlackRock itself. This risk is explicitly included among other key risk factors that could materially differ actual results from h... | [
"Step 1: Extract from source A - BlackRock explicitly lists geopolitical unrest as a material risk factor that could affect its business, financial condition, and results of operations.",
"Step 2: Extract from source B - Schwab mentions geopolitical unrest in the context of a broader macroeconomic environment but... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> MACRO_CONDITION <-[Impacted_By]- ORG | inter_document_cross_company | Financials | Asset Management & Custody Banks | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "BLK",
"name": "BLK",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Geopolitical_Unrest",
"name": "Geopolitical Unrest",
"type": "MACRO_CONDITION",
"year": null,
"idf_score": 6.573680166960646
},
{
... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "BLK_10k_2024.pdf",
"page_id": "page_38",
"chunk_id": "chunk_1",
"chunk_text": "## Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations\n\n## FORWARD-LOOKING STATE ME NTS\n\nThis report, and ot... |
qualitative_2hop_cross_company-00743 | What is the combined fair value of U.S. government and agency securities held by both MDT and MRK as of their respective fiscal years ending April 28, 2023, and December 31, 2023? | The combined fair value of U.S. government and agency securities held by MDT and MRK is $89 million (MDT) + $72 million (MRK) = $161 million. | [
"Step 1: From MDT's 10-K filing, the fair value of U.S. government and agency securities as of April 28, 2023, is $89 million.",
"Step 2: From MRK's 10-K filing, the fair value of U.S. government and agency securities as of December 31, 2023, is $72 million.",
"Step 3: To determine the combined fair value, we a... | qualitative | 2 | cross_company | chain | ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "MDT",
"name": "MDT",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "U.S._Government_and_Agency_Securities",
"name": "U.S. Government and Agency Securities",
"type": "FIN_INST",
"year": null,
"idf_score"... | [
{
"hop": 1,
"relationship": "Has_Stake_In",
"source_file": "MDT_10k_2023.pdf",
"page_id": "page_71",
"chunk_id": "chunk_6",
"chunk_text": "| | April 28, 2023 | April 28, 2023 | April 28, 2023 | April 28, 2023 |\n|---------------------... |
qualitative_2hop_cross_company-00744 | How do Cisco's and Microsoft's classifications of distinct performance obligations for software licenses differ in terms of revenue recognition timing, and what are the implications for their financial reporting? | Cisco classifies perpetual software licenses as distinct performance obligations and recognizes revenue upfront upon transfer of control, while Microsoft recognizes revenue from on-premises software licenses upfront at the point in time when the software is made available to the customer. However, when Microsoft alloca... | [
"Step 1: From evidence_source_a, Cisco recognizes revenue for perpetual software licenses upfront upon transfer of control as they are distinct performance obligations.",
"Step 2: From evidence_source_b, Microsoft recognizes revenue from distinct on-premises licenses upfront, but when software updates are include... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Determines]- ORG | inter_document_cross_company | Information Technology | Communications Equipment | hard | 5.475068 | 47 | [
{
"role": "start",
"id": "CSCO",
"name": "CSCO",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Distinct_Performance_Obligations",
"name": "Distinct Performance Obligations",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CSCO_10k_2022.pdf",
"page_id": "page_39",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## CRITICAL ACCOUNTING ESTIMATES\n\nThe preparation of financial statements and related disclosures in conformity with accounting p... |
qualitative_2hop_cross_company-00745 | How does the difference in the number of merchandise categories between Target and Sam's Club relate to the potential flexibility each company has in managing gross margin variation across their product offerings? | Target manages its business across six core merchandise categories and explicitly states that gross margins vary depending on the type of merchandise within those categories. Sam's Club organizes its offerings into four merchandise categories, which also experience variation in gross margins. With more distinct categor... | [
"Step 1: Extract from Target's 10-K - Target operates across six core merchandise categories and specifically notes that gross margins vary depending on the type of merchandise.",
"Step 2: Extract from Sam's Club's 10-K - Sam's Club organizes its merchandise into four categories and also acknowledges that gross m... | qualitative | 2 | cross_company | chain | ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Consumer Staples Merchandise Retail | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "TGT",
"name": "TGT",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Merchandise_Categories",
"name": "Merchandise Categories",
"type": "PRODUCT",
"year": null,
"idf_score": 5.8805329864007
},
{
... | [
{
"hop": 1,
"relationship": "Has_Stake_In",
"source_file": "TGT_10k_2024.pdf",
"page_id": "page_5",
"chunk_id": "chunk_1",
"chunk_text": "## Merchandise Sales by Fulfillment Channel\n\n## Financial Highlights\n\nFor information on key financial highlights, see Part II, Item 7, Management's D... |
qualitative_2hop_cross_company-00746 | How does Honeywell's production of sustainable aviation fuels, as part of its UOP business unit, potentially influence FedEx's compliance costs under CORSIA and the EU Emissions Trading Scheme, given FedEx's reliance on qualifying sustainable aviation fuel purchases as a compliance mechanism? | Honeywell’s UOP business unit produces sustainable aviation fuels, which are a qualifying compliance mechanism under both CORSIA and the EU ETS. FedEx has stated that its compliance costs under these programs will depend in part on its ability to utilize sustainable aviation fuels and the price of such fuels. Therefore... | [
"Step 1: Extract from source A - FedEx states that compliance with CORSIA and the EU ETS will increase operating expenses, and the cost depends on factors including the price and availability of qualifying sustainable aviation fuels.",
"Step 2: Extract from source B - Honeywell’s UOP business unit produces sustai... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Sustainable_Aviation_Fuels",
"name": "Sustainable Aviation Fuels",
"type": "PRODUCT",
"year": null,
"idf_score": 5.8805329864007
},
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "FDX_10k_2024.pdf",
"page_id": "page_18",
"chunk_id": "chunk_1",
"chunk_text": "DOT's approval and generally requires a bilateral agreement between the U.S. and the foreign government. In addition, the carrier must then be granted the ... |
qualitative_2hop_cross_company-00747 | How do the EMA regulatory risks described in Gilead Sciences' (GILD) and Thermo Fisher Scientific's (TMO) 2023 10-K filings differ in terms of potential financial and operational consequences, and what specific regulatory actions could each company face if they fail to comply with EMA requirements? | Gilead Sciences (GILD) faces potential delays or denial of product approvals, restrictions on product use, and possible withdrawal of products from the market due to EMA regulations. These risks could significantly impact GILD's commercialization efforts and future revenue streams. Thermo Fisher Scientific (TMO), on th... | [
"Step 1: Extract from source A (GILD) - GILD's regulatory risks include delays or denial of marketing approvals, restrictions on product use, and potential product withdrawal, which could materially affect commercial success.",
"Step 2: Extract from source B (TMO) - TMO faces risks of product recalls, injunctions... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "GILD",
"name": "GILD",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "EMA_Regulations",
"name": "EMA Regulations",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.8805329864007
},
{
... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "GILD_10k_2023.pdf",
"page_id": "page_25",
"chunk_id": "chunk_1",
"chunk_text": "## Regulatory\tand\tOther\tLegal\tRisks\n\n## Our\t operations\t depend\t on\t compliance\t with\t complex\t FDA\t and\t comparable\t international\t regu... |
qualitative_2hop_cross_company-00748 | BKNG issues 4.25% Senior Notes due May 2029 with annual interest payments in May, while HD holds a $1,600 million stake in 4.25% Senior Notes due April 2046 with semi-annual interest payments. What is the difference in the total number of interest payments each company will make over the life of these respective notes,... | BKNG will make 6 total interest payments on its 4.25% Senior Notes due May 2029, while HD will make 30 total interest payments on its 4.25% Senior Notes due April 2046, resulting in a difference of 24 total interest payments. | [
"Step 1: From BKNG's filing, extract that the 4.25% Senior Notes due May 2029 have annual interest payments in May.",
"Step 2: Calculate BKNG's total interest payments: From May 2023 issuance to May 2029 maturity is 6 years, so 6 annual payments.",
"Step 3: From HD's filing, extract that the 4.25% Senior Notes ... | qualitative | 2 | cross_company | chain | ORG -[Pays_Interest_On]-> FIN_INST <-[Has_Stake_In]- ORG | inter_document_cross_company | Consumer Discretionary | Hotels, Resorts & Cruise Lines | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "BKNG",
"name": "BKNG",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "4.25%_Senior_Notes",
"name": "4.25% Senior Notes",
"type": "FIN_INST",
"year": null,
"idf_score": 6.168215058852481
},
{
"ro... | [
{
"hop": 1,
"relationship": "Pays_Interest_On",
"source_file": "BKNG_10k_2023.pdf",
"page_id": "page_101",
"chunk_id": "chunk_2",
"chunk_text": "| Other Senior Notes | Date of Issuance | Timing of Interest Payments |\n|-----------------------------------... |
qualitative_2hop_cross_company-00749 | How does Honeywell's 5.3 percentage point decrease in its non-U.S. effective tax rate in 2024, influenced by global minimum taxes, contrast with FedEx's exposure to potential increases in effective tax rate due to the same global minimum tax framework? | Honeywell experienced a 5.3 percentage point decrease in its non-U.S. effective tax rate in 2024, partly due to changes in accruals on foreign tax matters and discrete adjustments, even as it faced increased expense from global minimum taxes. In contrast, FedEx explicitly notes exposure to adverse changes in tax laws, ... | [
"Step 1: Extract from evidence_source_a - FedEx is exposed to changes in tax laws, including global minimum taxes, which could significantly increase its effective tax rate and financial burden.",
"Step 2: Extract from evidence_source_b - Honeywell's non-U.S. effective tax rate decreased by 5.3 percentage points ... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Global_Minimum_Taxes",
"name": "Global Minimum Taxes",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.8805329864007
... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "FDX_10k_2024.pdf",
"page_id": "page_38",
"chunk_id": "chunk_1",
"chunk_text": "distributed throughout the world, there are concentrations of key assets within our networks that are exposed to adverse weather conditions or localized r... |
qualitative_2hop_cross_company-00750 | How do EMA regulations impact both Gilead Sciences (GILD) and Thermo Fisher Scientific (TMO) in terms of their clinical and manufacturing operations, and what specific risks does each company highlight regarding noncompliance with these regulations? | EMA regulations impact both Gilead Sciences (GILD) and Thermo Fisher Scientific (TMO) by imposing strict requirements on clinical trial design, manufacturing processes, and regulatory compliance. GILD highlights that its clinical trials are subject to EMA regulations and that failure to meet trial endpoints or comply w... | [
"Step 1: Extract from source A (GILD) - GILD mentions that its clinical trials are subject to EMA regulations and that failure to meet endpoints or regulatory standards could lead to delays or discontinuation of development programs, including impairment charges.",
"Step 2: Extract from source B (TMO) - TMO state... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "GILD",
"name": "GILD",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "EMA_Regulations",
"name": "EMA Regulations",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.8805329864007
},
{
... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "GILD_10k_2023.pdf",
"page_id": "page_23",
"chunk_id": "chunk_1",
"chunk_text": "We\tface\tnumerous\trisks\tand\tuncertainties\twith\tour\tclinical\ttrials\tthat\tcould\tresult\tin\tdelays\tor\tprevent\tcompletion\tof the\tdevelopment\... |
qualitative_2hop_cross_company-00751 | What is the difference in the way Colgate-Palmolive (CL) and Target (TGT) account for shipping and handling costs, and how does this affect the comparability of their gross profit margins? | Colgate-Palmolive reports shipping and handling costs as part of Selling, General and Administrative (SG&A) expenses, while Target includes these costs in Cost of Sales. As a result, Colgate-Palmolive's gross profit margin appears higher by 880 basis points in 2024 compared to if these costs were included in Cost of Sa... | [
"Step 1: From CL's 10-K, shipping and handling costs are reported in SG&A expenses, not in Cost of Sales, and this results in a higher gross profit margin by 880 bps in 2024.",
"Step 2: From TGT's 10-K, there is no indication that shipping and handling is treated differently from industry norms, implying that the... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Supplier_Finance_Programs",
"name": "Supplier Finance Programs",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.0696027701843... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_57",
"chunk_id": "chunk_1",
"chunk_text": "## (Dollars in Millions Except Per S hare Amounts)\n\nIn August 2023, the FASB issued ASU No. 2023-05, 'Business Combinations-Joint Venture Formations (Subto... |
qualitative_2hop_cross_company-00752 | How do FedEx's accounting policy for spare parts obsolescence and Honeywell's provision of aircraft spare parts and maintenance services interact to shape their respective cost structures in aviation operations? | FedEx accounts for spare parts obsolescence by providing allowances for excess or obsolete parts identified currently and those expected to be on hand when aircraft are retired. These allowances are expensed over the estimated useful life of the related aircraft and engines. This policy indicates that FedEx spreads out... | [
"Step 1: Extract from source A - FedEx provides allowances for spare parts obsolescence and expenses them over the estimated useful life of the related aircraft and engines.",
"Step 2: Extract from source B - Honeywell provides spare parts and maintenance services (including predictive maintenance via Honeywell F... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> PRODUCT <-[Produces]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Spare_Parts",
"name": "Spare Parts",
"type": "PRODUCT",
"year": null,
"idf_score": 5.657389435086491
},
{
"role": "end",
"... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "FDX_10k_2024.pdf",
"page_id": "page_87",
"chunk_id": "chunk_1",
"chunk_text": "## FEDEX CORPORATION\n\n## NOTES TO CONSOLIDATED FINANCIAL STATEMENTS\n\nCREDIT RISK. We routinely grant credit to many of our customers for transportation ... |
qualitative_2hop_cross_company-00753 | How does the shared exposure to U.S. federal anti-kickback laws, as described in the 2024 10-K filings, create distinct compliance risks for MDT's device reimbursement processes and UNH's Medicaid and Medicare contract operations, and what are the specific regulatory consequences each company could face if noncompliant... | MDT faces compliance risks under U.S. federal anti-kickback laws due to its involvement in federally funded healthcare programs like Medicare and Medicaid, where it must avoid improper financial arrangements that could influence referrals for reimbursed items. If MDT fails to comply, it could face criminal and civil pe... | [
"Step 1: Extract from source A - MDT is subject to U.S. federal healthcare laws, including anti-kickback statutes, particularly in relation to claims submitted for items reimbursed under federally funded programs such as Medicare and Medicaid. MDT must comply with the Physician Payments Sunshine Act, which requires... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Health Care | Health Care Equipment | hard | 5.187386 | 47 | [
{
"role": "start",
"id": "MDT",
"name": "MDT",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Anti-Kickback_Laws",
"name": "Anti-Kickback Laws",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.187385805840755
},... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "MDT_10k_2024.pdf",
"page_id": "page_15",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## Trade Regulations\n\nThe movement of products, services, technology, know-how, and investment across borders subjects us to exte... |
qualitative_2hop_cross_company-00754 | How do Accenture's and Adobe's approaches to generative AI differ in terms of strategic benefits and regulatory risks? | Accenture leverages generative AI as part of its broader technology strategy to enhance creative processes, solve client challenges, and deliver advanced, ethically sound, and sustainable solutions. This strategic use of generative AI is aimed at helping clients reinvent customer engagement. In contrast, Adobe has acti... | [
"Step 1: From evidence_source_a, extract Accenture’s strategic use of generative AI to enhance creative processes and deliver client solutions that are 'advanced, ethically sound and sustainable.'",
"Step 2: From evidence_source_b, extract Adobe’s development of Adobe Firefly and its focus on incorporating AI acr... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG | inter_document_cross_company | Information Technology | IT Consulting & Other Services | medium | 4.494239 | 47 | [
{
"role": "start",
"id": "ACN",
"name": "ACN",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Generative_AI",
"name": "Generative AI",
"type": "CONCEPT",
"year": null,
"idf_score": 4.4942386252808095
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "ACN_10k_2024.pdf",
"page_id": "page_9",
"chunk_id": "chunk_1",
"chunk_text": "Table of C ontents\n\nACCENTURE 2024 FORM 10-K\n\nItem 1. Business\n\n6\n\ntechnology. We leverage the combined power of strategy, data and A I (including g... |
qualitative_2hop_cross_company-00755 | How does the implementation of the 15% global minimum tax impact both Booking.com's financial operations and Home Depot's tax planning, given their respective international and U.S. tax exposures? | The 15% global minimum tax negatively impacts Booking.com's results of operations and cash flows due to its large international presence and the complexity of implementing new tax rules across jurisdictions. For Home Depot, while the 15% minimum tax under the Inflation Reduction Act had no impact on its effective tax r... | [
"Step 1: Extract from source A - Booking.com is negatively impacted by the 15% global minimum tax due to its international operations and complex compliance requirements.",
"Step 2: Extract from source B - Home Depot experienced no impact from the 15% minimum tax in fiscal 2023, but is monitoring the OECD's BEPS ... | qualitative | 2 | cross_company | chain | ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Consumer Discretionary | Hotels, Resorts & Cruise Lines | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "BKNG",
"name": "BKNG",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "15%_Minimum_Tax",
"name": "15% Minimum Tax",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 5.657389435086491
},
{... | [
{
"hop": 1,
"relationship": "Negatively_Impacts",
"source_file": "BKNG_10k_2023.pdf",
"page_id": "page_21",
"chunk_id": "chunk_1",
"chunk_text": "rate,\tincreasing\tthe\tpercentage\tof\tGILTI\tsubject\tto\ttax\tin\tthe\tUnited\tStates,\tor\tother\tchanges\tto\tU.S.\tfederal\ttax\tlaws\tcould... |
qualitative_2hop_cross_company-00756 | How do the competitive pressures described by MetLife and Wells Fargo differently influence their strategic investments in financial strength and regulatory compliance, given their respective exposures to insurance and banking regulatory frameworks? | MetLife emphasizes adaptability to market changes, financial strength, and technological efficiency as key differentiators in the competitive life insurance industry. This is evident in their focus on underwriting many group insurance products annually and the potential for group purchasers to seek more favorable terms... | [
"Step 1: Extract from source A - MetLife notes that adaptability to market changes, financial strength, and technological efficiency are key differentiators in the competitive life insurance industry. It also mentions the potential for group purchasers to seek more favorable terms from competitors.",
"Step 2: Ext... | qualitative | 2 | cross_company | chain | ORG -[Competes_With]-> COMP <-[Competes_With]- ORG | inter_document_cross_company | Financials | Life & Health Insurance | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "MET",
"name": "MET",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "State_Farm",
"name": "State Farm",
"type": "COMP",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": ... | [
{
"hop": 1,
"relationship": "Competes_With",
"source_file": "MET_10k_2023.pdf",
"page_id": "page_26",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\nIf\tthe\tIRS\tultimately\tdetermines\tthat\tthe\tdistribution\tis\ttaxable,\tthe\tdistribution\tcould\tbe\ttreated\tas\ta\ttax... |
qualitative_2hop_cross_company-00757 | Considering the presence of both companies in Kansas, what is the combined number of major manufacturing and warehousing facilities in Kansas for Colgate-Palmolive's Pet Nutrition segment and the total number of Target stores in Kansas as of February 1, 2025? | Colgate-Palmolive has a major manufacturing and warehousing facility in Kansas for its Pet Nutrition segment, and Target operates 17 stores in Kansas as of February 1, 2025. The combined total is 18 facilities and stores in Kansas. | [
"Step 1: Extract from source A - Colgate-Palmolive has a major manufacturing and warehousing facility in Kansas for its Pet Nutrition segment.",
"Step 2: Extract from source B - Target operates 17 stores in Kansas as of February 1, 2025.",
"Step 3: Synthesize - Combine the number of major facilities in Kansas f... | qualitative | 2 | cross_company | chain | ORG -[Operates_In]-> GPE <-[Operates_In]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Kansas",
"name": "Kansas",
"type": "GPE",
"year": null,
"idf_score": 5.069602770184371
},
{
"role": "end",
"id": "TGT",
... | [
{
"hop": 1,
"relationship": "Operates_In",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_25",
"chunk_id": "chunk_1",
"chunk_text": "## ITEM 2. PROPERTIES\n\nWe own or lease approximately 315 properties, which include manufacturing, distribution, research and development and office fa... |
qualitative_2hop_cross_company-00758 | How does the compliance with Federal Motor Vehicle Safety Standards (FMVSS) impact both General Motors and Tesla, particularly in terms of regulatory obligations and potential financial consequences when factoring in Tesla’s revenue from regulatory credit sales? | Both General Motors and Tesla are required to comply with FMVSS under NHTSA regulations, which mandates that vehicles meet safety standards or face costly recalls. GM highlights that noncompliance could lead to substantial recall costs, while Tesla self-certifies compliance with FMVSS for its vehicles. Additionally, Te... | [
"Step 1: Extract from GM_10k_2022.pdf - GM states that noncompliance with FMVSS could result in substantial recall costs.",
"Step 2: Extract from TSLA_10k_2022.pdf - Tesla self-certifies compliance with FMVSS and earns revenue from regulatory credit sales, which totaled $1.78 billion in 2022.",
"Step 3: Synthes... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "FMVSS",
"name": "FMVSS",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "GM_10k_2022.pdf",
"page_id": "page_16",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## GENERAL MOTORS COMPANY AND SUBSIDIARIES\n\n## Vehicle Safety\n\nU.S. Requirements The National Traffic and Motor Vehicle Safety A... |
qualitative_2hop_cross_company-00759 | How do DOT regulations related to greenhouse gas emissions influence the operational strategies and compliance costs of FedEx and Union Pacific, given their respective exposure to international and domestic regulatory frameworks? | FedEx is subject to CORSIA, a global market-based program aimed at offsetting carbon dioxide emissions for international aviation, which is expected to increase FedEx's operating expenses. The magnitude of this increase depends on factors such as the number of flights subject to CORSIA, fleet fuel efficiency, and the p... | [
"Step 1: Extract from evidence_source_a - FedEx is subject to CORSIA, which requires offsetting emissions above a baseline, increasing operating expenses based on factors like flight numbers and carbon credit prices.",
"Step 2: Extract from evidence_source_a - FedEx also faces regulatory exposure from EPA adoptio... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "DOT_Regulations",
"name": "DOT Regulations",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.168215058852481
},
{
... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "FDX_10k_2022.pdf",
"page_id": "page_26",
"chunk_id": "chunk_1",
"chunk_text": "In 2016, the International Civil Aviation Organization ('ICAO') passed a resolution adopting CORSIA, which is a global, marketbased measure for purchasing ... |
qualitative_2hop_cross_company-00760 | How does the difference in the scale and resolution timeline of tax examinations between Amgen and CVS Health reflect on their respective financial exposures and potential impacts on future tax liabilities? | Amgen is dealing with a significant unresolved IRS examination for 2010–2012 involving profit allocations between its U.S. and Puerto Rico entities, with no resolution timeline provided, indicating a potentially large and prolonged financial exposure. In contrast, CVS Health reports that substantially all material stat... | [
"Step 1: Extract from source A - Amgen is under IRS examination for 2010–2012 with proposed adjustments related to profit allocation between U.S. and Puerto Rico entities, and no resolution timeline is given.",
"Step 2: Extract from source B - CVS Health reports $330 million of unrecognized tax benefits that, if ... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> LITIGATION <-[Discloses]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "AMGN",
"name": "AMGN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Tax_Examination_Results",
"name": "Tax Examination Results",
"type": "LITIGATION",
"year": null,
"idf_score": 6.573680166960646
},... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "AMGN_10k_2023.pdf",
"page_id": "page_84",
"chunk_id": "chunk_1",
"chunk_text": "Rebates\tinclude\tprimarily\tamounts\tpaid\tto\tpayers\tand\tproviders\tin\tthe\tUnited\tStates,\tincluding\tthose\tpaid\tto\tstate\tMedicaid programs,\ta... |
qualitative_2hop_cross_company-00761 | How do jurisdictional restrictions related to regulatory compliance impact both Colgate-Palmolive (CL) and Costco (COST) differently, given CL's exposure to global regulatory bodies and COST's specific challenges in California and Canada? | Colgate-Palmolive (CL) faces risks from global regulatory authorities that could restrict the use of ingredients or packaging, potentially leading to product reformulation, recalls, or reputational damage. These jurisdictional restrictions could result in civil remedies like fines or injunctions, directly affecting the... | [
"Step 1: Extract from evidence_source_a - Colgate-Palmolive (CL) is subject to global regulatory authorities that could restrict the use of ingredients or packaging, potentially leading to product reformulation, recalls, or reputational damage.",
"Step 2: Extract from evidence_source_b - Costco (COST) faces chall... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Jurisdictional_Restrictions",
"name": "Jurisdictional Restrictions",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.1682... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_19",
"chunk_id": "chunk_1",
"chunk_text": "Commission, the Consumer Product Safety Commission, the Occupational Safety and Health Administration and the Environmental Protection Agency, regulate diff... |
qualitative_2hop_cross_company-00762 | How do the differing compliance strategies of GM and Tesla with respect to CAFE standards reflect in their respective financial commitments and revenue streams related to electric vehicle production? | GM has committed over $35 billion through 2025 to invest in electric vehicles (EVs) and autonomous vehicles (AVs) as part of its strategy to eliminate tailpipe emissions from new light-duty vehicles by 2035. This investment supports compliance with global CAFE standards and GHG regulations. In contrast, Tesla generates... | [
"Step 1: Extract from source A - GM has committed over $35 billion through 2025 to accelerate its transformation plan focused on electric vehicles to comply with global CAFE and GHG regulations.",
"Step 2: Extract from source B - Tesla earns revenue through the sale of automotive regulatory credits (ZEV, GHG, fue... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "CAFE_Standards",
"name": "CAFE Standards",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.168215058852481
},
{
"... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "GM_10k_2022.pdf",
"page_id": "page_14",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## GENERAL MOTORS COMPANY AND SUBSIDIARIES\n\nfederal CAFE and GHG rulemakings and related litigation and the finality of CARB's re... |
qualitative_2hop_cross_company-00763 | How do the dividend restrictions tied to capital adequacy metrics at MetLife, Inc. and the regulatory limitations on subsidiary dividend payments at Wells Fargo & Company reflect different mechanisms through which financial holding companies are constrained in their ability to distribute capital to shareholders? | MetLife, Inc. is prohibited from declaring dividends on its Floating Rate Non-Cumulative Preferred Stock, Series A, if it fails to meet specified capital adequacy, net income, and stockholders' equity levels. This restriction is directly tied to its financial health metrics. In contrast, Wells Fargo & Company faces reg... | [
"Step 1: Extract from source A - MetLife, Inc. cannot declare dividends on Series A preferred stock if it fails to meet specified capital adequacy, net income, and stockholders' equity levels.",
"Step 2: Extract from source B - Wells Fargo’s subsidiary banks are limited in the amount of dividends they may pay wit... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Financials | Life & Health Insurance | medium | 4.781921 | 47 | [
{
"role": "start",
"id": "MET",
"name": "MET",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Dividend_Restrictions",
"name": "Dividend Restrictions",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 4.78192069773259... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "MET_10k_2023.pdf",
"page_id": "page_285",
"chunk_id": "chunk_3",
"chunk_text": "\nIn\tthe\ttable\tabove,\tdividends\ton\teach\tseries\tof\tpreferred\tstock\tare\tpayable\tin\tarrears\tfor\tthe\tperiods\tspecified,\tif\tdeclared.\n\nMe... |
qualitative_2hop_cross_company-00764 | What is the combined total of unrecognized compensation costs related to nonvested equity awards (RSUs, stock options, and performance units) as of December 31, 2023, for both Amgen and CVS Health, and how does each company estimate the fair value of awards that include a market condition tied to a comparator group? | The combined total of unrecognized compensation costs as of December 31, 2023, is $1,288 million. Amgen has $498 million in unrecognized costs related to nonvested RSUs and stock options, while CVS Health has $790 million in unrecognized costs related to restricted stock units and performance stock units. Both companie... | [
"Step 1: Extract from source A - Amgen has $498 million of unrecognized compensation cost related to nonvested RSUs and stock options as of December 31, 2023.",
"Step 2: Extract from source B - CVS Health has $790 million of total unrecognized compensation cost related to restricted stock units and performance st... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> COMP <-[Depends_On]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "AMGN",
"name": "AMGN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Comparator_Group",
"name": "Comparator Group",
"type": "COMP",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "en... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "AMGN_10k_2023.pdf",
"page_id": "page_126",
"chunk_id": "chunk_3",
"chunk_text": "\nThe\ttotal\tintrinsic\tvalues\tof\toptions\texercised\tduring\tthe\tyears\tended\tDecember\t31,\t2023,\t2022\tand\t2021,\twere\t$33\tmillion, $67\tmill... |
qualitative_2hop_cross_company-00765 | How much total tax benefit did Colgate-Palmolive receive from dividends on ESOP shares over the three years 2022 to 2024, and how does this compare to the total ESOP-related tax deduction Costco reported over the same period? | Colgate-Palmolive received a total tax benefit of $52 million from dividends on ESOP shares over the three years (2022: $19, 2023: $17, 2024: $16). Costco reported a total ESOP-related tax deduction of $168 million over the same period (2022: $23, 2023: $25, 2024: $120). Therefore, Costco's ESOP-related tax deduction w... | [
"Step 1: From Colgate's 10-K filing, extract the dividends paid on ESOP shares for 2022 ($19), 2023 ($17), and 2024 ($16) to calculate the total tax benefit over three years.",
"Step 2: From Costco's 10-K filing, extract the ESOP-related tax deductions for 2022 ($23), 2023 ($25), and 2024 ($120) to calculate the ... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 5.320917 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "ESOP",
"name": "ESOP",
"type": "FIN_INST",
"year": null,
"idf_score": 5.320917198465278
},
{
"role": "end",
"id": "COST",
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_97",
"chunk_id": "chunk_1",
"chunk_text": "## COLGATE-PALMOLIVE COMPANY\n\n## Notes to Consolidated Financial Statements (continued)\n\n(Dollars in Millions Ex cept Share and Per Share Amounts)\n\n## ... |
qualitative_2hop_cross_company-00766 | How does GM's explicit financial focus on used vehicles, generating $1,896 million in revenue, compare with Tesla's strategic use of used vehicle remarketing as a mechanism to support new vehicle sales, and what does this reveal about their differing approaches to the used vehicle market? | GM reports used vehicles as a distinct revenue stream under its automotive segment, generating $1,896 million in revenue in 2022, which indicates a more formalized and financially significant role for used vehicles within its broader automotive sales. In contrast, Tesla does not disclose specific financial figures for ... | [
"Step 1: Extract from GM's 10-K - GM generated $1,896 million in used vehicle revenue in 2022, indicating a formalized and quantifiable role in its financial structure.",
"Step 2: Extract from Tesla's 10-K - Tesla describes its used vehicle business as a strategic mechanism to support new vehicle sales through tr... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> PRODUCT <-[Remarkets]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Used_Vehicles",
"name": "Used Vehicles",
"type": "PRODUCT",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "GM_10k_2022.pdf",
"page_id": "page_67",
"chunk_id": "chunk_6",
"chunk_text": "| | Year Ended December 31, 2019 | Year Ended December 31, 2019 | Year Ended December 31, 2019 | Year Ended December ... |
qualitative_2hop_cross_company-00767 | How do Boeing and Caterpillar's disclosures about their third-party guarantee liabilities reflect their respective risk exposures, particularly considering Boeing's potential termination liabilities and Caterpillar's history with dealer performance guarantees? | Boeing disclosed $160 million in potential termination liabilities to suppliers related to unauthorized future missions, indicating a significant exposure tied to unfulfilled contractual obligations. Caterpillar, on the other hand, reported a much smaller liability of $3 million for dealer performance guarantees at the... | [
"Step 1: Extract Boeing's potential termination liabilities of $160 million related to unauthorized missions from evidence_source_a.",
"Step 2: Extract Caterpillar's dealer performance guarantee liability of $3 million at the end of 2023 from evidence_source_b.",
"Step 3: Compare the nature of liabilities—Boein... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> FIN_INST <-[Has_Liability]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | hard | 5.320917 | 47 | [
{
"role": "start",
"id": "BA",
"name": "BA",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Third-Party_Guarantees",
"name": "Third-Party Guarantees",
"type": "FIN_INST",
"year": null,
"idf_score": 5.320917198465278
},
{
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "BA_10k_2023.pdf",
"page_id": "page_87",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\nnotification\tby\ta\tparachute\tsupplier\tof\tan\tissue\tidentified\tthrough\ttesting.\tA\tcrewed\tflight\ttest\tis\tnow\tplanned\t... |
qualitative_2hop_cross_company-00768 | How do the differences in the treatment of anti-dilutive stock options and RSUs between Colgate-Palmolive (CL) and Costco (COST) affect the comparability of their Basic EPS calculations? | Colgate-Palmolive (CL) reports that for the year ended December 31, 2024, an average of 295,968 stock options were anti-dilutive and excluded from diluted EPS calculations, while Costco (COST) only mentions the treasury stock method applied to RSUs without disclosing any anti-dilutive RSUs for the same period. This dis... | [
"Step 1: From CL's 10-K, extract the number of anti-dilutive stock options excluded from diluted EPS in 2024: 295,968.",
"Step 2: From COST's 10-K, note that while diluted EPS uses the treasury stock method on RSUs, there is no disclosure of any anti-dilutive RSUs excluded.",
"Step 3: Synthesize - The lack of a... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 5.320917 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Basic_EPS_Calculation",
"name": "Basic EPS Calculation",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 5.320917198465278
},
... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_110",
"chunk_id": "chunk_3",
"chunk_text": "\nBasic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common st... |
qualitative_2hop_cross_company-00769 | How do the reimbursement pressures described in AMGN's and CVS's 2023 10-K filings collectively impact the profitability of both companies, particularly in light of AMGN's reliance on third-party payer coverage and CVS's exposure to price compression in its PBM business? | AMGN states that its profitability is negatively affected by pricing and reimbursement pressures from government and commercial third-party payers. This is a critical risk since its sales depend heavily on such coverage. Similarly, CVS notes that reimbursement pressures, particularly in its PBM business, are causing pr... | [
"Step 1: Extract from AMGN 2023 10-K - 'Pricing and reimbursement pressures have affected, and are likely to continue to affect, our profitability.'",
"Step 2: Extract from CVS 2023 10-K - 'A significant increase in price compression and/or reimbursement pressures could occur, which could require us to reevaluate... | qualitative | 2 | cross_company | chain | ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "AMGN",
"name": "AMGN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Reimbursement_Pressures",
"name": "Reimbursement Pressures",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.168215058852481
}... | [
{
"hop": 1,
"relationship": "Negatively_Impacts",
"source_file": "AMGN_10k_2023.pdf",
"page_id": "page_36",
"chunk_id": "chunk_1",
"chunk_text": "## Item\t1A. RISK\tFACTORS\n\nThis\t report\t and\t other\t documents\t we\t file\t with\t the\t SEC\t contain\t forward-looking\t statements\t th... |
qualitative_2hop_cross_company-00770 | What specific financial consequences do Apple and Accenture disclose in their 10-K filings related to property damage risks, and how do these risks differ in terms of operational context and liability exposure? | Apple discloses that property damage risks from design and manufacturing defects could lead to product liability claims, recalls, product replacements or modifications, write-offs of inventory, property, plant and equipment or intangible assets, and significant warranty and other expenses, including litigation costs an... | [
"Step 1: From Apple's 10-K, extract the financial consequences of property damage risks, including product liability claims, recalls, product replacements, write-offs of inventory and equipment, warranty expenses, litigation costs, and regulatory fines.",
"Step 2: From Accenture's 10-K, extract the financial expo... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG | inter_document_cross_company | Information Technology | Technology Hardware, Storage & Peripherals | medium | 4.271095 | 47 | [
{
"role": "start",
"id": "AAPL",
"name": "AAPL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Property_Damage",
"name": "Property Damage",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 4.2710950739666
},
{
"role": ... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "AAPL_10k_2024.pdf",
"page_id": "page_12",
"chunk_id": "chunk_1",
"chunk_text": "## The Company's products and services may be affected from time to time by design and manufacturing defects that could materially adversely affect the C... |
qualitative_2hop_cross_company-00771 | How do CL's and COST's differing allocations to U.S. Treasury and agency securities reflect contrasting strategic priorities in their broader investment frameworks, particularly in terms of liquidity management and risk exposure? | CL allocates approximately 30% of its U.S. pension fixed income portfolio to U.S. Treasury and agency securities, with the remainder invested in other government and corporate bonds. This suggests a moderate risk posture that balances liquidity with diversification across fixed income instruments. In contrast, COST mai... | [
"Step 1: From evidence_source_a, CL invests approximately 30% of its U.S. pension fixed income portfolio in U.S. Treasury and agency securities, with the rest in other government and corporate bonds.",
"Step 2: From evidence_source_b, COST limits its short-term investments to U.S. government and agency obligation... | qualitative | 2 | cross_company | chain | ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG | inter_document_cross_company | Consumer Staples | Household Products | hard | 5.069603 | 47 | [
{
"role": "start",
"id": "CL",
"name": "CL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Agency_Securities",
"name": "Agency Securities",
"type": "FIN_INST",
"year": null,
"idf_score": 5.069602770184371
},
{
"role": "... | [
{
"hop": 1,
"relationship": "Invests_In",
"source_file": "CL_10k_2024.pdf",
"page_id": "page_100",
"chunk_id": "chunk_3",
"chunk_text": "\nPooled funds primarily invest in U.S. and foreig n equity securities, debt and money market securities. (1)\n\nThe fix ed income securities are traded ov... |
qualitative_2hop_cross_company-00772 | How do GM's fleet sales to leasing companies and Tesla's accounts receivable from leasing companies differ in terms of their direct financial implications for each company's cash flow and profitability? | GM's fleet sales to leasing companies are generally less profitable than retail sales, which directly affects its profitability per vehicle. Tesla, on the other hand, has accounts receivable from leasing companies tied to financing products, and while Tesla does not disclose a specific profitability impact, it does mai... | [
"Step 1: Extract from GM's filing - Fleet sales to leasing companies are 'generally less profitable than retail sales to end customers,' indicating a direct impact on per-unit profitability.",
"Step 2: Extract from Tesla's filing - Accounts receivable include amounts from leasing companies, and Tesla maintains an... | qualitative | 2 | cross_company | chain | ORG -[Supplies]-> COMP <-[Discloses]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | hard | 5.880533 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Leasing_Companies",
"name": "Leasing Companies",
"type": "COMP",
"year": null,
"idf_score": 5.8805329864007
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Supplies",
"source_file": "GM_10k_2022.pdf",
"page_id": "page_8",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n## GENERAL MOTORS COMPANY AND SUBSIDIARIES\n\nAs discussed above, total vehicle sales and market share data provided in the table above... |
qualitative_2hop_cross_company-00773 | How do Apple and Accenture each describe their financial and operational exposure to intellectual property infringement risks, and what specific business areas are highlighted in their respective 2024 10-K filings? | Apple highlights that competitors imitate its products and infringe on its intellectual property, which could harm its competitive position and require costly legal actions to protect its rights. This affects its hardware and software offerings, including key products like iPhones, iPads, and proprietary services such ... | [
"Step 1: Extract from AAPL 2024 10-K - Apple states that competitors imitate its products and infringe on its intellectual property, which could affect its competitive edge and require legal enforcement.",
"Step 2: Extract from ACN 2024 10-K - Accenture discloses that it may be liable for indemnifying clients in ... | qualitative | 2 | cross_company | chain | ORG -[Faces]-> RISK_FACTOR <-[Impacted_By]- ORG | inter_document_cross_company | Information Technology | Technology Hardware, Storage & Peripherals | medium | 4.271095 | 47 | [
{
"role": "start",
"id": "AAPL",
"name": "AAPL",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Intellectual_Property_Infringement",
"name": "Intellectual Property Infringement",
"type": "RISK_FACTOR",
"year": null,
"idf_score":... | [
{
"hop": 1,
"relationship": "Faces",
"source_file": "AAPL_10k_2024.pdf",
"page_id": "page_5",
"chunk_id": "chunk_1",
"chunk_text": "## Services\n\n## Advertising\n\nThe Company's advertising services include third-party licensing arrangements and the Company's own advertising platforms.\n\n#... |
qualitative_2hop_cross_company-00774 | What was the combined impact of MDLZ's 2023 Ricolino acquisition on its candy-related net revenues and how does this compare to the proportion of candy within TGT's overall grocery and snack offerings in 2024? | MDLZ's 2023 acquisition of Ricolino added $507 million in net revenues (on a constant currency basis) to its business, which included candy among the product categories contributing to favorable volume/mix growth. Meanwhile, candy is explicitly listed as one of the product categories within TGT's grocery and snack offe... | [
"Step 1: Extract from evidence_source_a - MDLZ's acquisition of Ricolino added $507 million in net revenues on a constant currency basis in 2023, with candy contributing to favorable volume/mix.",
"Step 2: Extract from evidence_source_b - TGT includes 'candy' as part of its grocery and snack offerings under its m... | qualitative | 2 | cross_company | chain | ORG -[Positively_Impacts]-> PRODUCT <-[Produces]- ORG | inter_document_cross_company | Consumer Staples | Packaged Foods & Meats | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "MDLZ",
"name": "MDLZ",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Candy",
"name": "Candy",
"type": "PRODUCT",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
"id": "TGT"... | [
{
"hop": 1,
"relationship": "Positively_Impacts",
"source_file": "MDLZ_10k_2024.pdf",
"page_id": "page_51",
"chunk_id": "chunk_3",
"chunk_text": "\n## 2024 compared with 2023\n\nNet rev enues decreased $80 million (1.6%), due to unfav orable impact of currency-related items (6.2 pp) and unfa... |
qualitative_2hop_cross_company-00775 | What specific compliance obligations under China's Data Security Law are mentioned by both Nike and Starbucks in their 2024 10-K filings, and how do these obligations impact their respective operational expenses and international business strategies? | Both Nike and Starbucks explicitly mention compliance with China's Data Security Law as part of their broader data privacy and cybersecurity risk disclosures. Nike notes that compliance with such laws, including China's Data Security Law, is 'costly and time-consuming' and may involve 'significant resources' to protect... | [
"Step 1: Extract from source A (Nike 10-K) - Nike explicitly mentions China's Data Security Law in the context of global data privacy regulations and states that compliance is costly and time-consuming, requiring significant resources.",
"Step 2: Extract from source B (Starbucks 10-K) - Starbucks also references ... | qualitative | 2 | cross_company | chain | ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Consumer Discretionary | Apparel, Accessories & Luxury Goods | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "NKE",
"name": "NKE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Data_Security_Law",
"name": "Data Security Law",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.573680166960646
},
... | [
{
"hop": 1,
"relationship": "Complies_With",
"source_file": "NKE_10k_2024.pdf",
"page_id": "page_24",
"chunk_id": "chunk_1",
"chunk_text": "## Table of C ontents\n\nelim inate, adjust or im pose new quotas, duties, tariffs, safeguard m easures, anti-dum ping duties, cargo restrictions to pre... |
qualitative_2hop_cross_company-00776 | What is the total number of credit agreements involving Citibank, N.A. as an agent or administrative entity in 2022 and 2023 for both Boeing and Caterpillar, based on their respective 10-K filings? | The total number of credit agreements involving Citibank, N.A. as an agent or administrative entity for Boeing and Caterpillar in 2022 and 2023 is 8. | [
"Step 1: Extract from source A - Boeing has 3 credit agreements involving Citibank, N.A. as administrative agent: the 364-Day Credit Agreement (August 24, 2023), the Five-Year Credit Agreement (August 24, 2023), and the Three-Year Credit Agreement (August 25, 2022).",
"Step 2: Extract from source B - Caterpillar ... | qualitative | 2 | cross_company | chain | ORG -[Partners_With]-> COMP <-[Partners_With]- ORG | inter_document_cross_company | Industrials | Aerospace & Defense | medium | 4.433614 | 47 | [
{
"role": "start",
"id": "BA",
"name": "BA",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Citibank,_N.A.",
"name": "Citibank, N.A.",
"type": "COMP",
"year": null,
"idf_score": 4.433614003464375
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Partners_With",
"source_file": "BA_10k_2023.pdf",
"page_id": "page_125",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## Item\t14.\tPrincipal\tAccountant\tFees\tand\tServices\n\nOur\tindependent\tregistered\tpublic\taccounting\tfirm\tis\tDeloit... |
qualitative_2hop_cross_company-00777 | How does MET's exposure to reinvestment risk through its long-term care business and retained asset accounts interact with V's interest rate risk in its investment portfolio to affect their respective financial strategies under a rising interest rate scenario? | Under a rising interest rate scenario, MET benefits over time as higher reinvestment rates on cash flows more than offset the negative impacts of higher interest crediting rates and lower income from derivative positions. MET faces reinvestment risk on approximately 6% of its invested assets annually through 2027, part... | [
"Step 1: MET experiences reinvestment risk on 6% of its invested assets annually through 2027, particularly in long-term care policies and retained asset accounts with guaranteed minimum crediting rates.",
"Step 2: MET's rising interest rate scenario analysis indicates that higher reinvestment returns eventually ... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> RISK_FACTOR <-[Discloses]- ORG | inter_document_cross_company | Financials | Life & Health Insurance | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "MET",
"name": "MET",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Reinvestment_Risk",
"name": "Reinvestment Risk",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 6.168215058852481
},
{
"rol... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "MET_10k_2024.pdf",
"page_id": "page_53",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nOur long-term care business experiences gross margin compression as we cannot reduce interest crediting rates for established clai... |
qualitative_2hop_cross_company-00778 | How do the unique product features emphasized by Pfizer (PFE) compare with the competitive factors highlighted by Thermo Fisher Scientific (TMO) in terms of influencing market positioning and customer preference in the healthcare and life sciences sectors? | Pfizer emphasizes that unique product features such as greater efficacy, better patient ease of use, and fewer side effects are critical in securing favorable formulary placement with Managed Care Organizations (MCOs), which directly affects product demand and financial performance. In contrast, Thermo Fisher Scientifi... | [
"Step 1: Extract from source A - Pfizer notes that 'unique product features, such as greater efficacy, better patient ease of use, or fewer side effects' are key to securing formulary inclusion and competing effectively against alternative therapies.",
"Step 2: Extract from source B - Thermo Fisher states that it... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG | inter_document_cross_company | Health Care | Pharmaceuticals | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "PFE",
"name": "PFE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Unique_Product_Features",
"name": "Unique Product Features",
"type": "PRODUCT",
"year": null,
"idf_score": 6.573680166960646
},
{
... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "PFE_10k_2024.pdf",
"page_id": "page_16",
"chunk_id": "chunk_1",
"chunk_text": "medicines, or are using utilization m anagem ent tools or lim iting access on form ularies. T his trend is likely to continue. P rivate third-party payors,... |
qualitative_2hop_cross_company-00779 | How does Oracle's Autonomous Database's capability to align workforce deployment with business activity forecasts contrast with Accenture's risk of increased costs from misalignment between demand and workforce capacity? | Oracle's Autonomous Database is specifically designed to help organizations align workforce deployment with business activity forecasts by providing easy-to-use analytics tools and machine learning capabilities that enable real-time analysis and dynamic workload management. This technological automation is intended to ... | [
"Step 1: From evidence_source_b, extract that Oracle Autonomous Database is designed to 'align workforce deployment with business activity forecasts' through analytics and machine learning.",
"Step 2: From evidence_source_a, extract that Accenture faces profitability risks if they fail to maintain appropriate ali... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> CONCEPT <-[Guides_On]- ORG | inter_document_cross_company | Information Technology | IT Consulting & Other Services | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "ACN",
"name": "ACN",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Workforce_Alignment",
"name": "Workforce Alignment",
"type": "CONCEPT",
"year": null,
"idf_score": 6.168215058852481
},
{
"rol... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "ACN_10k_2022.pdf",
"page_id": "page_22",
"chunk_id": "chunk_1",
"chunk_text": "## Financial Risks\n\nOur profitability could materially suffer if we are unable to obtain favorable pricing for our services and solutions, if we are unab... |
qualitative_2hop_cross_company-00780 | What percentage of MDLZ's 2024 net revenues came from non-U.S. markets, and how might this geographic footprint provide a strategic advantage for distributing beverages globally compared to TGT's beverage offerings within their grocery segment? | 74.0% of MDLZ's 2024 net revenues came from non-U.S. markets, indicating a strong international presence across approximately 80 countries. This extensive global distribution network, combined with beverages being one of MDLZ's five core product categories, creates a strategic advantage for international beverage distr... | [
"Step 1: From MDLZ's 10-K, extract the 74.0% non-U.S. revenue figure and the fact that beverages are one of their five product categories.",
"Step 2: From TGT's 10-K, extract that beverages are part of their grocery offerings, which also include a wide range of other food and food service items.",
"Step 3: Synt... | qualitative | 2 | cross_company | chain | ORG -[Produces]-> PRODUCT <-[Produces]- ORG | inter_document_cross_company | Consumer Staples | Packaged Foods & Meats | hard | 5.475068 | 47 | [
{
"role": "start",
"id": "MDLZ",
"name": "MDLZ",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Beverages",
"name": "Beverages",
"type": "PRODUCT",
"year": null,
"idf_score": 5.475067878292536
},
{
"role": "end",
"id... | [
{
"hop": 1,
"relationship": "Produces",
"source_file": "MDLZ_10k_2024.pdf",
"page_id": "page_6",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\n- Scale sustainable snacking . We continue to focus significant efforts to driv e progress against our core initiativ ... |
qualitative_2hop_cross_company-00781 | How do 3M and Raytheon differ in the specific business separation transactions and associated contingent tax liabilities disclosed in their 2023 10-K filings? | 3M disclosed contingent tax liabilities related to its 2022 split-off of the Food Safety Division using a Reverse Morris Trust structure, which was intended to be tax-free. If this transaction were later determined to fail tax-free treatment, 3M could face significant liabilities that could materially impact its busine... | [
"Step 1: From 3M's 2023 10-K, extract that the 2022 split-off of the Food Safety Division via a Reverse Morris Trust structure was intended to be tax-free and that failure to qualify could result in significant contingent tax liabilities.",
"Step 2: From Raytheon's 2023 10-K, extract that the 2020 distributions o... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG | inter_document_cross_company | Industrials | Industrial Conglomerates | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "MMM",
"name": "MMM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Tax-Free_Treatment",
"name": "Tax-Free Treatment",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.573680166960646
},... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "MMM_10k_2023.pdf",
"page_id": "page_55",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## NOTE\t3.\tDivestitures\n\n2023\tDivestitures\tand\tPreviously\tAnnounced\tDivestitures: In\tAugust\t2023,\t3M\tcompleted\tthe\... |
qualitative_2hop_cross_company-00782 | How do the approaches of BK and JPM differ in terms of Rule 10b5-1 trading arrangements and non-Rule 10b5-1 trading arrangements for their officers or directors in 2024? | BK indicates that certain officers or directors have participated in plans such as the dividend reinvestment plan, employee stock purchase plan, and 401(k) plan, which may be designed to satisfy Rule 10b5-1 or may constitute non-Rule 10b5-1 trading arrangements. In contrast, JPM reports that no non-Rule 10b5-1 trading ... | [
"Step 1: From BK's 2024 10-K, it is stated that certain officers or directors have made elections to participate in various plans (dividend reinvestment, employee stock purchase, and 401(k)), which may be designed to satisfy Rule 10b5-1 or may constitute non-Rule 10b5-1 trading arrangements.",
"Step 2: From JPM's... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG | inter_document_cross_company | Financials | Asset Management & Custody Banks | medium | 4.868932 | 47 | [
{
"role": "start",
"id": "BK",
"name": "BK",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Rule_10b5-1_Trading_Arrangements",
"name": "Rule 10b5-1 Trading Arrangements",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_scor... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "BK_10k_2024.pdf",
"page_id": "page_12",
"chunk_id": "chunk_1",
"chunk_text": "Changes in Internal Control over Financial Reporting\n\nIn the ordinary course of business, we may routinely modify, upgrade or enhance our internal controls... |
qualitative_2hop_cross_company-00783 | How do Pfizer's and Thermo Fisher's disclosed uses of Swedish krona hedging instruments differ in terms of their stated hedging objectives and the specific types of transactions they cover? | Pfizer hedges Swedish krona exposure primarily to mitigate the impact on net income from the re-measurement of foreign exchange-denominated transactions and intercompany inventory sales, which are hedged up to two years into the future. Thermo Fisher, on the other hand, uses Swedish krona hedging instruments predominan... | [
"Step 1: Extract from source A - Pfizer hedges Swedish krona exposure to mitigate the impact on net income from re-measurement of foreign exchange-denominated transactions and intercompany inventory sales hedged up to two years.",
"Step 2: Extract from source B - Thermo Fisher uses short-term forward and option c... | qualitative | 2 | cross_company | chain | ORG -[Hedges]-> FIN_INST <-[Hedges]- ORG | inter_document_cross_company | Health Care | Pharmaceuticals | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "PFE",
"name": "PFE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Swedish_Krona",
"name": "Swedish Krona",
"type": "FIN_INST",
"year": null,
"idf_score": 5.657389435086491
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Hedges",
"source_file": "PFE_10k_2024.pdf",
"page_id": "page_84",
"chunk_id": "chunk_5",
"chunk_text": "\n(a)\n\nReclassified to the current portion of long-term debt. (b)\n\nOur long-term debt is generally redeemable by us at any time at varying redemption price... |
qualitative_2hop_cross_company-00784 | How does Oracle's belief in blockchain's role within its SaaS offerings contrast with the risk that blockchain introduces to Accenture's business operations, based on their respective 2022 10-K filings? | Oracle believes that blockchain is a key advanced technology natively incorporated into its Cloud SaaS offerings, enhancing productivity and business processes by providing secure data isolation, flexible upgrades, and self-service access controls. In contrast, Accenture identifies blockchain as part of a set of evolvi... | [
"Step 1: From evidence_source_a, extract that Accenture identifies blockchain as one of the evolving technologies that may introduce operational, legal, regulatory, ethical, and other risks that could negatively affect its business.",
"Step 2: From evidence_source_b, extract that Oracle believes blockchain is a c... | qualitative | 2 | cross_company | chain | ORG -[Impacted_By]-> PRODUCT <-[Believes]- ORG | inter_document_cross_company | Information Technology | IT Consulting & Other Services | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "ACN",
"name": "ACN",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Blockchain",
"name": "Blockchain",
"type": "PRODUCT",
"year": null,
"idf_score": 4.964242254526545
},
{
"role": "end",
"id... | [
{
"hop": 1,
"relationship": "Impacted_By",
"source_file": "ACN_10k_2022.pdf",
"page_id": "page_17",
"chunk_id": "chunk_1",
"chunk_text": "## Item 1A. Risk Factors\n\nIn addition to the other information set forth in this report, you should carefully consider the following factors which could... |
qualitative_2hop_cross_company-00785 | What is the combined targeted allocation percentage for international equity securities in the pension investment strategies of both MDLZ and TGT as disclosed in their 2024 10-K filings? | The combined targeted allocation percentage for international equity securities in the pension investment strategies of MDLZ and TGT is 16%. MDLZ has a targeted allocation of 8% for international equity securities in its non-U.S. plans, while TGT has a targeted allocation of 8% for international equity securities in it... | [
"Step 1: Extract from source A - MDLZ has a targeted allocation of 8% for international equity securities in its non-U.S. plans.",
"Step 2: Extract from source B - TGT has a targeted allocation of 8% for international equity securities in its asset allocation.",
"Step 3: Synthesize - Combine the targeted alloca... | qualitative | 2 | cross_company | chain | ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Packaged Foods & Meats | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "MDLZ",
"name": "MDLZ",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "International_Equity_Securities",
"name": "International Equity Securities",
"type": "FIN_INST",
"year": null,
"idf_score": 4.964242... | [
{
"hop": 1,
"relationship": "Invests_In",
"source_file": "MDLZ_10k_2024.pdf",
"page_id": "page_104",
"chunk_id": "chunk_3",
"chunk_text": "\nFor the MDLZ Global Plan, our assets hav e been exchanged for buy-in annuity contracts to cov er all plan liabilities. For our remaining U.S. plans, ou... |
qualitative_2hop_cross_company-00786 | How does the reliance on licensees by both NKE and SBUX create a shared vulnerability in maintaining brand reputation, given the specific risks each company outlines regarding licensee control and brand misuse? | Both NKE and SBUX rely on licensees to maintain brand integrity, but neither has full control over licensee actions. NKE states that misuse of its brand by licensees or negative publicity involving them could have a material adverse effect on its brand value. Similarly, SBUX acknowledges that failures by licensees to m... | [
"Step 1: Extract from NKE's 10-K - 'The misuse of a brand by or negative publicity involving a licensee could have a material adverse effect on that brand and on us.'",
"Step 2: Extract from SBUX's 10-K - 'Failures by our licensees or business providers to comply with the laws or regulations... could erode consum... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> COMP <-[Depends_On]- ORG | inter_document_cross_company | Consumer Discretionary | Apparel, Accessories & Luxury Goods | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "NKE",
"name": "NKE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Licensees",
"name": "Licensees",
"type": "COMP",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": "S... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "NKE_10k_2024.pdf",
"page_id": "page_20",
"chunk_id": "chunk_1",
"chunk_text": "## Table of C ontents\n\nbusiness continuity plans, or those of our vendors, do not effectively resolve the issues in a tim ely m anner, we could experienc... |
qualitative_2hop_cross_company-00787 | How does the potential failure to achieve tax-free treatment for MMM's planned spin-off of its Health Care business compare with RTX's successful tax-free treatment of its Carrier and Otis dispositions, and what are the respective financial implications for each company? | MMM's planned spin-off of its Health Care business is conditional on receiving a private letter ruling from the IRS and a tax opinion from external counsel to ensure tax-free treatment for U.S. federal income tax purposes. If the spin-off is determined to be taxable, MMM could incur significant income tax liabilities t... | [
"Step 1: Extract from evidence_source_a - MMM's spin-off is intended to be tax-free but is conditional on IRS ruling and tax opinion, and failure could result in significant tax liabilities.",
"Step 2: Extract from evidence_source_b - RTX determined that its Carrier and Otis dispositions qualified as tax-free und... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG | inter_document_cross_company | Industrials | Industrial Conglomerates | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "MMM",
"name": "MMM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Tax-Free_Treatment",
"name": "Tax-Free Treatment",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.573680166960646
},... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "MMM_10k_2023.pdf",
"page_id": "page_16",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n* Changes\tin\ttax\trates,\tlaws,\tor\tregulations\tcould\tadversely\timpact\tour\tfinancial\tresults.\n\nThe\tCompany's\tbusines... |
qualitative_2hop_cross_company-00788 | How would a 10% depreciation in the Swedish krona impact the shareholders' equity of Pfizer and Thermo Fisher Scientific, given their different approaches to foreign currency hedging? | A 10% depreciation in the Swedish krona would reduce Thermo Fisher Scientific's shareholders' equity by a quantified amount of approximately $2.05 billion, as stated in its 10-K filing, due to its exposure to foreign exchange rate fluctuations on its net investments in international subsidiaries. In contrast, Pfizer do... | [
"Step 1: Extract from evidence_source_a - Pfizer hedges foreign exchange risk using derivative instruments and foreign currency debt, including exposure to the Swedish krona.",
"Step 2: Extract from evidence_source_b - Thermo Fisher discloses that a 10% depreciation in functional currencies (including the Swedish... | qualitative | 2 | cross_company | chain | ORG -[Hedges]-> FIN_INST <-[Hedges]- ORG | inter_document_cross_company | Health Care | Pharmaceuticals | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "PFE",
"name": "PFE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Swedish_Krona",
"name": "Swedish Krona",
"type": "FIN_INST",
"year": null,
"idf_score": 5.657389435086491
},
{
"role": "end",
... | [
{
"hop": 1,
"relationship": "Hedges",
"source_file": "PFE_10k_2024.pdf",
"page_id": "page_84",
"chunk_id": "chunk_5",
"chunk_text": "\n(a)\n\nReclassified to the current portion of long-term debt. (b)\n\nOur long-term debt is generally redeemable by us at any time at varying redemption price... |
qualitative_2hop_cross_company-00789 | How does the maximum share payout range differ between AMD's and CSCO's PRSU programs, and what specific performance-based vesting limits are stated for each company? | The difference in maximum share payout between AMD's and CSCO's PRSU programs is 100%. AMD's PRSU recipients can vest in up to 250% of the target shares, while CSCO's PRSU recipients can vest in up to 150% of the target shares for financial performance metrics or comparative market-based returns. This reflects a more e... | [
"Step 1: From evidence_source_a, AMD's PRSU program allows recipients to receive up to 250% of the Target Shares granted, depending on performance achievement.",
"Step 2: From evidence_source_b, CSCO's PRSU program caps vesting at 150% of the target shares for financial performance metrics or comparative market-b... | qualitative | 2 | cross_company | chain | ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Information Technology | Semiconductors | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "AMD",
"name": "AMD",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "PRSUs",
"name": "PRSUs",
"type": "FIN_INST",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": "CSCO"... | [
{
"hop": 1,
"relationship": "Introduces",
"source_file": "AMD_10k_2022.pdf",
"page_id": "page_70",
"chunk_id": "chunk_3",
"chunk_text": "\n## Stock Repurchase Program\n\nIn May 2021, the Company's Board of Directors approved a stock repurchase program authorizing up to $4 billion of repurcha... |
qualitative_2hop_cross_company-00790 | How does the reliance on licensees for branded product distribution impact both NIKE's and Starbucks' brand reputation and financial performance, given their respective business models? | Both NIKE and Starbucks rely on licensees to distribute branded products, but the nature of their offerings and associated risks differ. NIKE licenses apparel, digital devices, and sports equipment, which are manufactured and sold by unaffiliated parties using NIKE-owned trademarks. This allows NIKE to expand its marke... | [
"Step 1: Extract from source A - NIKE licenses apparel, digital devices, and equipment to unaffiliated parties, who manufacture and sell these products using NIKE-owned trademarks.",
"Step 2: Extract from source B - Starbucks authorizes licensees, including retailers and foodservice operators, to provide branded ... | qualitative | 2 | cross_company | chain | ORG -[Depends_On]-> COMP <-[Depends_On]- ORG | inter_document_cross_company | Consumer Discretionary | Apparel, Accessories & Luxury Goods | hard | 6.168215 | 47 | [
{
"role": "start",
"id": "NKE",
"name": "NKE",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "Licensees",
"name": "Licensees",
"type": "COMP",
"year": null,
"idf_score": 6.168215058852481
},
{
"role": "end",
"id": "S... | [
{
"hop": 1,
"relationship": "Depends_On",
"source_file": "NKE_10k_2024.pdf",
"page_id": "page_4",
"chunk_id": "chunk_1",
"chunk_text": "## PART I\n\n## ITEM 1. BUSINESS\n\n## GENERAL\n\nNIKE , I nc. was incorporated in 1967 under the laws of the State of O regon. As used in this Annual R epo... |
qualitative_2hop_cross_company-00791 | How does the difference in the outcomes of the 2023 annual goodwill impairment testing between 3M and RTX reflect contrasting financial implications for each company's reporting units, and what specific goodwill-related actions did each company take during the year? | 3M had a $12.9 billion goodwill balance as of December 31, 2023, and although its annual goodwill impairment testing completed as of October 1, 2023, indicated no impairment for most reporting units, it did record a goodwill impairment charge related to the Advanced Materials reporting unit due to its commitment to exi... | [
"Step 1: Extract from evidence_source_a - 3M had $12.9 billion in goodwill as of December 31, 2023, and recorded a goodwill impairment charge related to the Advanced Materials reporting unit due to its exit from PFAS manufacturing.",
"Step 2: Extract from evidence_source_b - RTX completed its annual goodwill impa... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Industrials | Industrial Conglomerates | hard | 5.657389 | 47 | [
{
"role": "start",
"id": "MMM",
"name": "MMM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Annual_Goodwill_Impairment_Testing",
"name": "Annual Goodwill Impairment Testing",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_sco... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "MMM_10k_2023.pdf",
"page_id": "page_35",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\nFor\tthe\tyear\tended\tDecember\t31,\t2023,\tthe\tCompany\trecognized\tconsolidated\tdefined\tbenefit\tpre-tax\tpension\tand\tpos... |
qualitative_2hop_cross_company-00792 | How do Costco's use of fixed-price contracts for energy and PepsiCo's global purchasing programs, which also include fixed-price contracts, reflect different strategies to manage commodity price risk, and what specific financial exposure does each company aim to mitigate? | Costco uses fixed-price contracts for energy, particularly electricity and natural gas, to partially mitigate fluctuations in prices for these commodities used in retail and manufacturing operations, primarily in the U.S. and Canada. PepsiCo, on the other hand, employs global purchasing programs that include fixed-pric... | [
"Step 1: From evidence_source_a, Costco uses fixed-price contracts for energy (electricity and natural gas) to mitigate price fluctuations in these commodities used in its operations.",
"Step 2: From evidence_source_b, PepsiCo utilizes global purchasing programs that include fixed-price contracts to manage commod... | qualitative | 2 | cross_company | chain | ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG | inter_document_cross_company | Consumer Staples | Consumer Staples Merchandise Retail | medium | 4.868932 | 47 | [
{
"role": "start",
"id": "COST",
"name": "COST",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Fixed-Price_Contracts",
"name": "Fixed-Price Contracts",
"type": "FIN_INST",
"year": null,
"idf_score": 4.8689320747222204
},
{
... | [
{
"hop": 1,
"relationship": "Invests_In",
"source_file": "COST_10k_2022.pdf",
"page_id": "page_46",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nDefinite-lived intangible assets, which are not material, are included in other long-term assets on the consolidate... |
qualitative_2hop_cross_company-00793 | How much total after-tax net unrealized gain from cash flow hedging instruments does 3M expect to reclassify into earnings over the next 12 months, and how does this compare to the net cash receipts RTX received from settlement of derivative instruments not designated as hedging instruments during 2023? | 3M expects to reclassify approximately $26 million of after-tax net unrealized gain from cash flow hedging instruments into earnings over the next 12 months. RTX received net cash receipts of $14 million from the settlement of derivative instruments not designated as hedging instruments during 2023. Therefore, 3M's exp... | [
"Step 1: From MMM's 10-K filing, identify the expected after-tax net unrealized gain to be reclassified into earnings: $26 million.",
"Step 2: From RTX's 10-K filing, identify the net cash receipts from settlement of derivative instruments not designated as hedging instruments in 2023: $14 million.",
"Step 3: C... | qualitative | 2 | cross_company | chain | ORG -[Impacts]-> RISK_FACTOR <-[Faces]- ORG | inter_document_cross_company | Industrials | Industrial Conglomerates | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "MMM",
"name": "MMM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Foreign_Exchange_Rate_Risk",
"name": "Foreign Exchange Rate Risk",
"type": "RISK_FACTOR",
"year": null,
"idf_score": 4.964242254526545... | [
{
"hop": 1,
"relationship": "Impacts",
"source_file": "MMM_10k_2023.pdf",
"page_id": "page_74",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## NOTE\t15.\tSupplier\tFinance\tProgram\tObligations\n\nUnder\tsupplier\tfinance\tprograms,\t3M\tagrees\tto\tpay\tparticipating\tba... |
qualitative_2hop_cross_company-00794 | How does AXP's approach to recoveries in credit loss reserves contrast with PYPL's strategy through modification programs, particularly in light of AXP's $37 million partial recovery related to a corporate client bankruptcy? | AXP experienced a $37 million partial recovery in 2021 related to a corporate client bankruptcy that had previously resulted in a $53 million write-off in 2020. This indicates AXP's approach to credit losses includes the potential for recoveries after write-offs, which directly impacts its provision for credit losses. ... | [
"Step 1: From AXP's 10-K filing, we extract the specific $37 million partial recovery in 2021 related to a prior $53 million write-off, showing AXP's experience with recoveries after write-offs.",
"Step 2: From PYPL's 10-K filing, we note the company's use of modification programs as part of its broader strategy,... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Financials | Consumer Finance | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "AXP",
"name": "AXP",
"type": "ORG",
"year": 2022,
"idf_score": null
},
{
"role": "intermediate",
"id": "Modification_Programs",
"name": "Modification Programs",
"type": "ACCOUNTING_POLICY",
"year": null,
"idf_score": 6.573680166960646
}... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "AXP_10k_2022.pdf",
"page_id": "page_112",
"chunk_id": "chunk_3",
"chunk_text": "\n(a) We present a net write-off rate based on principal losses only (i.e., excluding interest and/or fees) to be consistent with industry convention. In a... |
qualitative_2hop_cross_company-00795 | In the 2023 fiscal year, how does Amgen's single business segment structure contrast with Pfizer's segment-specific categorization of Enbrel in its Specialty Care division, and what implications does this have for how each company reports the financial performance of Enbrel? | Amgen operates in a single business segment—human therapeutics—and therefore reports the financial performance of Enbrel as part of its consolidated results without separate segment disclosure. In contrast, Pfizer categorizes Enbrel under its Specialty Care segment, specifically within the Inflammation & Immunology sub... | [
"Step 1: Extract from evidence_source_a - Amgen operates in one business segment: human therapeutics.",
"Step 2: Extract from evidence_source_b - Pfizer categorizes Enbrel under its Specialty Care segment, specifically within Inflammation & Immunology.",
"Step 3: Synthesize - Amgen's single-segment reporting in... | qualitative | 2 | cross_company | chain | ORG -[Produces]-> PRODUCT <-[Produces]- ORG | inter_document_cross_company | Health Care | Biotechnology | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "AMGN",
"name": "AMGN",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Enbrel",
"name": "Enbrel",
"type": "PRODUCT",
"year": null,
"idf_score": 6.573680166960646
},
{
"role": "end",
"id": "PF... | [
{
"hop": 1,
"relationship": "Produces",
"source_file": "AMGN_10k_2023.pdf",
"page_id": "page_113",
"chunk_id": "chunk_1",
"chunk_text": "## AMGEN\tINC.\n\n## NOTES\tTO\tCONSOLIDATED\tFINANCIAL\tSTATEMENTS\n\nDecember\t31,\t2023\n\n## 1.\tSummary\tof\tsignificant\taccounting\tpolicies\n\n## B... |
qualitative_2hop_cross_company-00796 | What is the combined percentage allocation to international equity securities by both MO's pension and postretirement plans and TGT's actual allocation as of December 31, 2024? | The combined percentage allocation to international equity securities is 12%. MO's pension and postretirement plans each allocated approximately 2% to international equity securities, totaling 4%. TGT's actual allocation to international equity securities was 8%. Adding these together results in a total allocation of 1... | [
"Step 1: Extract from source A - MO's pension and postretirement plans each allocated approximately 2% to international equity securities, totaling 4%.",
"Step 2: Extract from source B - TGT's actual allocation to international equity securities was 8%.",
"Step 3: Synthesize - Adding MO's total international eq... | qualitative | 2 | cross_company | chain | ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG | inter_document_cross_company | Consumer Staples | Tobacco | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "MO",
"name": "MO",
"type": "ORG",
"year": 2024,
"idf_score": null
},
{
"role": "intermediate",
"id": "International_Equity_Securities",
"name": "International Equity Securities",
"type": "FIN_INST",
"year": null,
"idf_score": 4.9642422545... | [
{
"hop": 1,
"relationship": "Invests_In",
"source_file": "MO_10k_2024.pdf",
"page_id": "page_90",
"chunk_id": "chunk_1",
"chunk_text": "## Table of Contents\n\nindices, including, the Standard & Poor's 500 Index and Morgan Stanley Capital International ('MSCI') Europe, Australasia, and t... |
qualitative_2hop_cross_company-00797 | How do GM's use of intercompany loans for global liquidity management compare with Nike's use of intercompany transactions in their foreign currency risk management program? | GM utilizes intercompany loans as part of its global liquidity management strategy, with over 85% of its cash and marketable debt securities managed within North America and regional treasury centers. These loans help utilize funds across global operations as needed. In contrast, Nike employs intercompany transactions ... | [
"Step 1: Extract from source A - GM manages over 85% of its cash and marketable debt securities within North America and uses intercompany loans to utilize funds across global operations as needed.",
"Step 2: Extract from source B - Nike uses forward and option contracts to hedge certain intercompany transactions... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> FIN_INST <-[Excludes]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | medium | 4.964242 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Intercompany_Loans",
"name": "Intercompany Loans",
"type": "FIN_INST",
"year": null,
"idf_score": 4.964242254526545
},
{
"role":... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "GM_10k_2023.pdf",
"page_id": "page_38",
"chunk_id": "chunk_1",
"chunk_text": "## Table\tof\tContents\n\n## GENERAL\tMOTORS\tCOMPANY\tAND\tSUBSIDIARIES\n\nfocused\ton\tthe\tthree\tobjectives\tof\tour\tcapital\tallocation\tprogram:\t(1)\... |
qualitative_2hop_cross_company-00798 | Compare how the Railway Labor Act's mandatory mediation process affects labor risk exposure for Federal Express and Union Pacific, given Federal Express's nationwide unionization requirement and Union Pacific's 85% union representation across its 32,973-employee workforce? | The Railway Labor Act (RLA) imposes a mandatory mediation process through the National Mediation Board before any union can strike or employer can impose terms, which reduces the risk of sudden work stoppages for both companies. At Federal Express, all U.S. employees are subject to the RLA, requiring unionization to oc... | [
"Step 1: Extract from source A - Federal Express requires nationwide unionization under the RLA, with mandatory mediation before strikes, preventing localized disruptions.",
"Step 2: Extract from source B - Union Pacific has 85% of its 32,973 employees represented by unions under the RLA, with negotiations starti... | qualitative | 2 | cross_company | chain | ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG | inter_document_cross_company | Industrials | Air Freight & Logistics | hard | 6.57368 | 47 | [
{
"role": "start",
"id": "FDX",
"name": "FDX",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Railway_Labor_Act",
"name": "Railway Labor Act",
"type": "REGULATORY_REQUIREMENT",
"year": null,
"idf_score": 6.573680166960646
},
... | [
{
"hop": 1,
"relationship": "Subject_To",
"source_file": "FDX_10k_2023.pdf",
"page_id": "page_20",
"chunk_id": "chunk_1",
"chunk_text": "Labor . All\tU.S.\temployees\tat\tFederal\tExpress\tare\tcovered\tby\tthe\tRailway\tLabor\tAct\tof\t1926,\tas\tamended\t(the\t'RLA'),\twhile labor\trelatio... |
qualitative_2hop_cross_company-00799 | How do the evaluation dates used by GM and NKE to assess the effectiveness of their disclosure controls and procedures differ, and what does this suggest about the timing of their reporting processes? | GM evaluated the effectiveness of its disclosure controls and procedures as of December 31, 2023, while NKE conducted its evaluation as of May 31, 2024. This indicates a difference of approximately 5 months in the timing of their reporting cycles, suggesting that NKE finalized its assessment earlier in the fiscal calen... | [
"Step 1: Extract from GM's 10-K filing that the evaluation of disclosure controls and procedures was conducted as of December 31, 2023.",
"Step 2: Extract from NKE's 10-K filing that the evaluation of disclosure controls and procedures was conducted as of May 31, 2024.",
"Step 3: Compare the two evaluation date... | qualitative | 2 | cross_company | chain | ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG | inter_document_cross_company | Consumer Discretionary | Automobile Manufacturers | medium | 4.376456 | 47 | [
{
"role": "start",
"id": "GM",
"name": "GM",
"type": "ORG",
"year": 2023,
"idf_score": null
},
{
"role": "intermediate",
"id": "Effectiveness_of_Disclosure_Controls_and_Procedures",
"name": "Effectiveness of Disclosure Controls and Procedures",
"type": "ACCOUNTING_POLICY"... | [
{
"hop": 1,
"relationship": "Discloses",
"source_file": "GM_10k_2023.pdf",
"page_id": "page_104",
"chunk_id": "chunk_1",
"chunk_text": "## Item\t9.\tChanges\tin\tand\tDisagreements\twith\tAccountants\ton\tAccounting\tand\tFinancial\tDisclosure\n\nNone.\n\n*\t\t*\t\t*\t\t*\t\t*\t\t*\t\t*\n\n#... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.